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Abstract
Spir proteins are the founding members of the novel class of WH2-actin nucleators. A C-
terminal modified FYVE zinc finger motif is necessary to target Spir proteins towards in-
tracellular membranes. The function and regulation of the Spir actin organizers at vesicular
membranes is almost unknown. Live cell imaging analyses performed in this study show that
Spir-2 is localized at tubular vesicles. Cytoplasmic Spir-2-associated vesicles branch and form
protrusions, which can make contacts to the microtubule network, where the Spir-2 vesicles
stretch and slide along the microtubule filaments. The analysis of living HeLa cells express-
ing eGFP-tagged Spir-2, Spir-2-DKIND and Spir-2-DKW (lacking the 4 WH2 domains and
the KIND domain) showed Spir-2-associated tubular structures which differ in their length
and motility. Throughout the course of that study it could be shown that the tail domain
of the actin motor protein myosin Vb, as a force-generating molecule, is colocalizing and co-
immunoprecipitating with Spir-2-DKW. By using the tail domain of myosin Vb as a dominant
negative mutant for myosin Vb-dependent vesicle transport processes it could be shown that
Spir-2-DKW/MyoVb-cc-tail- associated vesicles exhibit an increased elongation. Moreover,
using the microtubule depolymerizing drug nocodazole it could be shown that the elonga-
tion and the motility of Spir-2-DKW-associated vesicles depends on an intact microtubule
cytoskeleton. Motility and morphological dynamics of Spir-2-associated vesicles is therefore
dependent on actin, actin motorproteins and microtubule filaments. These results propose a
model in which myosin/F-actin forces mediate vesicle branching, allowing the vesicles to move
to and in between the microtubule filaments and thereby providing a new degree of freedom
in vesicular motility. To determine the exact subcellular localization of Spir-2, colocaliza-
tion studies were performed. It could be shown that Spir-2 shows a partial colocalization to
Rab11a-positive compartments. Furthermore, Spir-2 exhibits an almost identical localization
to Arf1 and the Arf1 small G protein but not Rab11a could be immunoprecipitated with
Spir-2-DKW. This suggests, that Arf1 recruits Spir-2 to Arf1/Rab11a-positive membranes.
Another important function of the Spir-2 C-terminus is the membrane targeting by the FYVE
domain. By performing a protein-lipid overlay assay, it has been shown that purified GST-
and 6xHis-tagged Spir-2-DKW bind phosphatidic acid suggesting a mechanism in which Spir-2
is recruited to phosphatidic acid-enriched membranes. To further elucidate the mechanism in
which Spir-2 membrane-targeting could be regulated, interaction studies of C-terminal parts
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of Spir-2 revealed that the Spir-2 proteins interact directly.
Zusammenfassung
Spir Proteine sind die ersten beschriebenen Mitglieder der neuen Klasse der WH2-Aktin Nuk-
leatoren. Ein C-terminaler modifizierter FYVE Zinkfinger ist notwendig um Spir Proteine an
intrazelluläre Membranen zu bringen. Die Funktion und die Regulation dieser Aktin Nuk-
leatoren an vesikulären Membranen ist bis jetzt noch nahezu unbekannt.
In dieser Studie durchgeführte Live-cell-Imaging Experimente zeigten, dass Spir-2 an
tubulären Vesikeln lokalisiert ist. Zytoplasmatische Spir-2-assoziierte Vesikel formen Aus-
läufer, die Kontakte zum Mikrotubuli Netzwerk bilden. Spir-2 Vesikel haben die Fähigkeit sich
entlang des Mikrotubuli Zytoskeletts auszudehnen und daran entlang zu gleiten. Die Analyse
von lebenden HeLa Zellen, welche eGFP-Spir-2, eGFP-Spir-2-DKIND und eGFP-Spir-2-DKW
(Deletion der 4 WH2 Domänen sowie der KIND Domäne) Fusionsproteine exprimieren, zeigen
Spir-2-assoziierte tubuläre Vesikel, die sich in Länge und Beweglichkeit unterscheiden.
Während dieser Studie konnte außerdem gezeigt werden, dass die tail  Domäne des Aktin-
motors myosin Vb mit Spir-2-DKW kolokalisiert und koimmunopräzipitiert. Die Verwendung
der tail  Domäne als dominant negative Mutante für myosin Vb-abhängigen Vesikeltrans-
port zeigte, dass Spir-2-DKW/MyoVb-cc-tail-assoziierte Vesikel eine stark erhöhte Elonga-
tion aufweisen. Desweiteren konnte duch die Verwendung von Nocodazol, welches spezifisch
Mikrotubulifilamente depolymerisiert, gezeigt werden, dass die Elongation und die Motilität
der Spir-2-DKW-assoziierten Vesikel von einem intakten Mikrotubuli Zytoskelett abhängig
ist. Motilität und morphologische Dynamik der Spir-2-DKW-assoziierten Vesikel ist daher
abhängig von Aktinfilamenten, Aktin Motorproteinen und Mikrotubulifilamenten. Anhand
dieser Ergebnisse lässt sich ein Modell erstellen, in welchem eine Myosin/F-actin induzierte
Bewegung eine Verzweigung der Vesikel bewirkt. Dadurch ist eine Bewegung der Vesikel
zu Mikrotubulifilamenten aber auch zwischen verschiedenen Mikrotubulifilamenten möglich,
welches einen ganz neuen Freiheitsgrad in der vesikulären Bewegung eröffnet. Um die genaue
zelluläre Lokalisation von Spir-2 zu analysieren wurden Kolokalisationsstudien durchgeführt.
Hierbei konnte gezeigt werden, dass Spir-2 eine partielle Kolokalisation mit Rab11a-positiven
Kompartimenten zeigt. Außerdem weist Spir-2 eine nahezu identische Lokalisation zu Arf1 auf.
Arf1, aber nicht Rab11a, konnte mit Spir-2-DKW koimmunpräzipitiert werden. Arf1 könnte
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daher für die Rekrutierung von Spir-2 an Arf1/Rab11a-positive Membranen ausschlaggebend
sein.
Eine weitere wichtige Funktion des Spir-2 C-Terminus ist die Membranlokalisation, welche
durch die FYVE Domäne vermittelt wird. Mittels Protein-Lipid Bindungsstudien konnte
gezeigt werden, dass aufgereinigte GST- bzw. 6xHis-Spir-2-DKW-Fusionsproteine an Phos-
phatidylsäure binden. Dies deutet darauf hin, dass Spir-2 spezifisch zu Phosphatidylsäure-
positiven Membranen rekrutiert wird. Um die weitere Regulation der Spir-2 Membranlokali-
sation aufzuklären, wurden Protein-Protein-Interaktionsstudien durchgeführt, welche eine di-
rekte Interaktion von Spir-2 Proteinen anhand ihrer C-Termini ergaben.
v
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1 INTRODUCTION
1.1 Regulation of actin filament assembly
The assembly of actin monomers into filaments is a tightly regulated basic cellular function.
The dynamic assembly and disassembly of actin filaments is crucial for many cellular pro-
cesses, like migration, endocytosis, and cytokinesis. Eukaryotic cells use actin polymerization
to form contractile structures, to internalize extracellular materials, and to coordinate changes
in morphology (Welch and Mullins, 2002, Chesarone and Goode, 2009). Regulation is essen-
tial, because cells contain high concentrations of actin monomers, which have the ability to
polymerize. The actin monomer consist of two major domains each containing two subdomains
referred as subdomains 1-4 (Kabsch et al., 1990, Dominguez and Holmes, 2010). Two large
clefts are formed between the two major domains (Dominguez and Holmes, 2010). The lower
cleft mediates the binding to several actin-binding proteins (Dominguez, 2004, Oda et al.,
2009, Fujii et al., 2010), whereas the upper cleft provides the binding site for the nucleotide
and the associated Mg2+ (Otterbein et al., 2001). Each actin filament consists of two a-helical
protofilaments with a fast-growing barbed end (+end) and a pointed end (-end). Details
of the actin filament structure have been obtained from X-ray fiber diagrams (Holmes et al.,
1990, Oda et al., 2009, Oda and Maeda, 2010) and from electron cryo-microscopy (Fujii et al.,
2010, Holmes et al., 2003) but there is still no structure of ATP F-actin. The dissociation equi-
librium (ratio of the rate constants for dissociation and association of subunits) also known
as the critical concentration is lower at the barbed end (0.1 µm) than at the pointed end
(0.7 µm) (Pollard and Borisy, 2003) resulting in an asymmetric actin filament. ATP-bound
actin monomers associate to the barbed end, whereas ADP-actin monomers dissociate from
the pointed end, a process known as actin filament treadmilling (Pollard, 2007). Globular
actin (G-actin) is not an efficient ATPase in comparison to filamentous actin (F-actin). The
two major domains of an actin monomer undergo a propeller-twist upon polymerization, re-
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sulting in the stimulation of the ATPase activity (Oda and Maeda, 2010). ATP hydrolysis by
polymerized actin is irreversible (Carlier et al., 1988) and fast (with a half time of 2 seconds)
(Blanchoin and Pollard, 2002), whereas the dissociation of the g-phosphate is slow (with a
half time of 6 minutes) (Blanchoin and Pollard, 1999). The property of the ADP-Pi-actin
intermediate is identical to ATP-actin. ADP-actin dissociates from the actin filament more
rapidly than ATP-actin, suggesting that ATP hydrolyzation and dissociation of g-phosphate
could trigger actin filament disassembly in cells.
De novo assembly of filaments by pure actin monomers is unfavorable due to the fact
that actin dimers and trimers are unstable (Pollard and Borisy, 2003, Sept and McCammon,
2001). Otherwise, elongation of existing actin filaments is favorable and depends on the
concentration of ATP-actin monomers. There are several actin-binding proteins, which control
actin filament assembly (Dominguez, 2004). ADF/cofilins have been proposed to increase
the rate of treadmilling by promoting severing and dissociation of ADP-actin subunits from
filament ends (Carlier et al., 1997, Blanchoin et al., 2000, Yeoh et al., 2002). The actin binding
protein thymosin ß4 inhibits nucleotide exchange, whereas profilin, as the nucleotide exchange
factor, promotes nucleotide exchange and blocks actin nucleation at both ends of the filament
(Dominguez, 2007). Gelsolin is a F-actin capping and severing protein (McGough et al., 2003).
It has been shown that profilin binds actin-monomers more tightly than thymosin ß4. This
maintains a pool of association-competent actin-profilin, whereas a smaller fraction of actin
monomers bound to thymosin ß4 is kept in reserve.
Due to the fact, that de novo actin filament assembly is unfavorable, cells require actin
nucleators to overcome the kinetic barrier to filament nucleation. Furthermore, the expression
of different actin nucleation and elongation factors enables the cell to construct actin networks
with specialized architectures and function.
1.2 Actin nucleation factors
1.2.1 The Arp2/3 complex
The Arp2/3 complex is an important cellular actin nucleator (Machesky et al., 1994), which
together with its multiple nucleation promoting factors (NPFs) nucleates actin filaments of
various cellular structures (Welch and Mullins, 2002).
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The Arp2/3 complex consists of 7 subunits: two actin-related proteins, Arp2 and Arp3
within a complex with five other subunits: ARPC1 (for the 40-kDa subunit), ARPC2 (35-kDa
subunit), ARPC3 (21-kDa subunit), ARPC4 (20-kDa subunit), and ARPC5 (16-kDa subunit).
According to the dendritic nucleation model activated Arp2/3 complex nucleates new actin
branches in a 70º angle on the sides of existing actin mother filaments. The pointed end of the
daughter filament is anchord to the mother filament whereas the free barbed end grows away
from the Arp2/3 - F-actin complex. In the branch model Arp2 und Arp3 form an actin-like
dimer template for nucleation (Mullins et al., 1998, Pollard, 2007).
The Arp2/3 complex is active at the leading edge of motile cells, organizing actin filaments
during lamellipodia protrusion. Corresponding to the dendritic nucleation model lamellipo-
dial actin networks are generated through the branching of new filaments from the sides of
existing filaments, producing a dendritic array (Mullins et al., 1998). Recent results, using
electron tomography, show that actin filaments do not form dendritic arrays in vivo (Urban
et al., 2010), challenging the dendritic nucleation model. Therefore, if the branched network
is just an artefact of the 2-dimensional projections of densely packed 3-dimensional filament
networks, remains an open question.
The Arp2/3 complex is intrinsically inactive but is strongly activated by proteins called
nucleation promoting factors (NPFs), actin monomers and by pre-existing actin filaments.
In the crystal structure of the inactive bovine Arp2/3 complex, Arp2 and Arp3 are not in
this dimer-like conformation. This leads to the hypothesis that activation of the Arp2/3
complex involves a conformational change that brings Arp2 and Arp3 together. Binding of an
actin monomer than creates the actin-trimer, which is then followed by rapid actin filament
polymerization (Mullins et al., 1998, Robinson et al., 2001).
Major activators of the Arp2/3 complex are the Wiskott-Aldrich syndrome protein (WASP )
family of nucleation promoting factors. WASP, neuronal WASP (N-WASP) and SCAR/WAVE1-
3 (suppressor of cAMP receptor/WASP family verprolin homologous protein 1-3) were the first
identified members of Arp2/3 NPFs (Veltman and Insall, 2010). New members; WHAMM,
JMY and WASH, were recently discovered (Campellone et al., 2008, Linardopoulou et al.,
2007, Zuchero et al., 2009).
All proteins of the WASP-family contain a carboxy-terminal activation domain consisting
of one or two WH2 (WASP-homology) domains (also called verprolin homology domain, V-
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domain), the acidic (A) domain, which mediates the binding to the Arp2/3 complex, and an
intermediate conserved sequence (C) named cofilin homology domain (Veltman and Insall,
2010). The WH2 domain (Paunola et al., 2002, Chereau et al., 2005, Dominguez, 2007) binds
an actin monomer and is therefore crucial for the nucleation of a new actin filament (by
contributing an actin monomer for the actin trimer).
1.2.2 Formins
Formins are large multidomain proteins that form homodimers. All proteins of the formin-
family contain the highly conserved formin homology 2 (FH2) domain and a neighboring
proline rich FH1 domain. Phylogenetic analysis of FH2 domains show that metazoan formins
fall into eight groups, named: Dia (diaphanous); DAAM (dishevelled-associated activator of
morphogenesis); FRL (formin-related gene in leukocytes); FHOD (formin homology domain-
containing protein); INF1 (inverted formin); WHIF1 (also referred to as INF2); FMN (formin)
and delphilin (Schonichen and Geyer, 2010). Most eukaryotes have multiple formin isoforms.
FH2 domains have been shown to alter actin polymerization dynamics by accelerating de
novo filament nucleation, altering filament elongation and/or depolymerization rate and by
preventing filament barbed-end capping by capping proteins. It has been shown that the
crystal structure of the FH2 domain from budding yeast formin Bni1 is dimeric (Xu et al.,
2004). Other mammalian formin FH2 domains were also found to be dimeric (Harris et al.,
2004, Li and Higgs, 2005). Two FH2 domains form a head-to-tail doughnut-shaped dimer that
encircles the barbed end of the actin filament (Xu et al., 2004, Lu et al., 2007, Yamashita
et al., 2007, Otomo et al., 2005b).
Furthermore, FH2 domains have the ability to move processively with an elongating actin
filament barbed end (Shimada et al., 2004, Romero et al., 2004, Xu et al., 2004, Lu et al.,
2007, Romero et al., 2007). Each functional half of the FH2 dimer is called a hemi-dimer and
contains two F-actin binding sites (Xu et al., 2004). One side could dissociate to promote
incorporation of an additional actin monomer while the other side of the FH2 dimer remain
bound. In this way the FH2 dimer could move processively with the growing barbed end,
protecting it from capping proteins. By solving the crystal structure of the yeast Bni1p FH2
domain in complex with tetramethylrhodamine-actin it has been proposed that the FH2 dimer
exists in two different states: an open state, that allows actin subunit association or a closed
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state, that prevents polymerization. Interconversion between these states allows processive
barbed end polymerization and depolymerization in the presence of bound FH2 domain.
The addition of one actin subunit shifts the position of the open-closed equilibrium by one
unit forward along the filament (Otomo et al., 2005a).
The main feature of the N-terminal located FH1 domain is their high proline content. FH1
is a binding site for the actin monomer binding protein profilin (Kovar et al., 2003, Sagot et al.,
2002). Profilin-bound actin monomers cannot nucleate spontaneously, and they cannot add to
pointed ends but add to barbed ends (Pollard and Cooper, 1984, Pring et al., 1992, Pantaloni
and Carlier, 1993, Pollard et al., 2000). Thus, profilin inhibits spontaneous nucleation and only
when filaments are nucleated, they can use the profilin-bound actin monomers to elongate at
their barbed ends. FH1 domains can also mediate protein-protein interactions to SH3 or WW
domain-containing signaling proteins (Wallar and Alberts, 2003). Interactions between profilin
and the FH1 domain are crucial for the recruitment of actin monomers to the elongating actin
filament.
A common regulation mechanism of the formin protein family is autoinhibition. The C-
terminus of several formins includes a diaphanous autoregulatory domain (DAD), which can
mediate autoinhibition through binding to the N-terminus, a domain called diaphanous in-
hibitory domain (DID). DAD-DID interactions inhibit the ability of the FH2 domain to nucle-
ate actin filaments (Li and Higgs, 2003). One mechanism to release formins from autoinhibition
is the binding of Rho small G proteins to a N-terminal Rho-binding domain (Lammers et al.,
2005).
1.2.3 The WH2 domain containing nucleation factor Spir
The first informations about Spir function have been obtained from a Drosophila screen for
female sterile mutants (Manseau and Schupbach, 1989). The Drosophila spire and cappuc-
cino mutant phenotypes were found to be identical. The Cappuccino (Capu) protein is an
actin nucleation factor of the formin family. Mutation of spire and cappuccino affects both
the dorsal-ventral and the anterior-posterior axes of the Drosophila egg and embryo (Emmons
et al., 1995). The major phenotype of spire and cappuccino mutant Drosophila oocytes is a
premature microtubule-dependent fast streaming at stage 8, before the polarity axes have been
established (Theurkauf, 1994). Premature fast streaming has also been observed in chickadee
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mutants (the Drosophila actin monomer-binding protein profilin) and after treatment with
actin-depolymerizing drugs, like cytochalasin D (Manseau et al., 1996). These data suggest
that Spir, Cappuccino and profilin are required to nucleate actin filaments, which repress
premature microtubule-based cytoplasmic streaming. A current model has been proposed in
which Spire and Capu assemble a dynamic actin mesh in the oocyte cytoplasm (Dahlgaard
et al., 2007). During stages 5-10A, the mesh inhibits kinesin-dependent motility. When the
actin mesh is present, the oocyte microtubules always form an anterior-posterior gradient,
whereas they form cortical arrays when the mesh is absent. Once polarization factors a cor-
rectly targeted the actin mesh is disassembled at stage 10B. This relieves the inhibition of
kinesin-dependent movement and switches on fast ooplasmic streaming. A similar actin mesh
that is important for spindle positioning during asymmetric partitioning of the cytoplasm was
also found in vertebrate oocytes (Azoury et al., 2008, Li et al., 2008, Schuh and Ellenberg,
2008).
1.2.3.1 Domain structure of Spir-family proteins
All known Spir proteins share a common domain architecture. The N-terminus contains the
kinase non-catalytic C-lobe domain (KIND), which is a protein-protein interaction module.
The Spir KIND domain represents the isolated C-lobe of kinases and is catalytically inac-
tive (Ciccarelli et al., 2003). Regarding that the C-lobe of kinases mediates interaction with
upstream activator proteins and downstream targets, a possible function of the Spir KIND
domain could be the interaction with, or the recruitment of signaling proteins. A cluster of 4
WH2 domains is located in the central region of all Spir proteins. Spir proteins nucleate actin
polymerization by the binding of four actin monomers to the four WH2 domains (WH2-A -
WH2-D). Maximal nucleation activity requires all four WH2 domains and also the linker re-
gions between the WH2 domains, especially the third linker region (L-3) between WH2-C and
WH2-D. The deletion of WH2-C and WH2-D results in a nearly abolished nucleation activ-
ity, suggesting a model for Spir-induced actin polymerization, in which WH2-C and WH2-D
each bind one actin monomer and L-3 might promote actin dimer formation by stabilizing
the interaction of those two actin monomers. WH2-B and WH2-A than add two further actin
monomers to the initial dimer. It is supposed that Spir mediates the formation of the initial
dimer to nucleate one strand of the long-pitch filament helix (Quinlan et al., 2005).
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The C-terminus of Spir proteins consists of the Spir-box and the modified FYVE domain.
The Spir-box is highly conserved between the different Spir proteins. It shares sequence simi-
larity with a helical region of the Rab3A effector rabphilin-3A, which mediates the interaction
with the small G protein Rab3A (Kerkhoff et al., 2001, Ostermeier and Brunger, 1999). This
suggests, that the Spir-box could mediate binding to Rab small G proteins. The modified
FYVE domain is located adjacent to the Spir-box, at the C-terminus. FYVE zinc fingers
contain 8 cysteine residues, which bind two zinc ions (Misra and Hurley, 1999). FYVE do-
mains are membrane binding modules, forming a hydrophobic turret loop, which penetrates
the membrane (Kutateladze and Overduin, 2001, Psachoulia and Sansom, 2009). It has been
shown that mutation of the FYVE domain and deletion of the Spir-box of Drosophila p150
Spir disrupts the membranous localization of Spir (Kerkhoff et al., 2001). A common fea-
ture of FYVE domains is a cluster of basic amino acids between cysteines 2 and 3, which is
crucial for the binding to phosphatidylinositol 3-phosphate (PtdIns(3)P). The modified Spir
FYVE domain lacks the basic cluster and has a loop insertion between cysteines 6 and 7. This
suggests that Spir exhibits different phospholipid binding properties in comparison to other
FYVE domain containing proteins.
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Figure 1.1: Actin nucleation factors
Actin nucleation factors like the Arp2/3 complex, formins and the WH2-domain containing
actin nucleator Spir are required for the polymerization of free actin monomers. The Arp2/3
complex A, which is activated by binding to nucleation promoting factors, like N-WASP. B
Formins mediate actin nucleation and polymerization by forming a ring-like dimer structure in
which each FH2 domain binds two actins. The proline-rich FH1 domain binds profilin-actin.
C Spir proteins are the founding members of a class of WH2-domain containing actin nucle-
ation factors. Four WH2-domains in the central region of the protein bind 4 actin monomers.
Formin and Spir proteins nucleate unbranched filaments, whereas the Arp2/3 complex nucle-
ates branched filaments.
Figure adapted from Kerkhoff, 2006.
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1.2.3.2 Spir-formin cooperation
According to the identical phenotypes of cappuccino and spire mutants in Drosophila oocytes
it has been shown that Spir and Capu interact (Rosales-Nieves et al., 2006, Quinlan et al.,
2007). Quinlan et al. found that the KIND domain of Spir binds to the Capu FH2 domain.
Furthermore the KIND domain inhibits actin nucleation by the Capu FH2 domain whereas
Capu FH2 leads to an increased actin nucleation of Spir KIND WH2 but not Spir WH2
(Quinlan et al., 2007).
Vertebrate genomes encode two spir genes, spir-1 and spir-2 (Schumacher et al., 2004,
Pleiser et al., 2010), which show a high similarity. There are two Capu homologs in mammals,
formin-1 (FMN-1) (Zhou et al., 2006, Dettenhofer et al., 2008, Kobielak et al., 2004) and
formin-2 (FMN-2) (Leader and Leder, 2000, Leader et al., 2002). It has been shown that spir-
1 and formin-2 show a similar expression pattern during mouse embryogenesis and in the adult
mouse brain (Schumacher et al., 2004). Mouse spir-2 was detected in epithelial cells of the
digestive tract and in neuronal cells of the nervous system (Pleiser et al., 2010). Analogous
to Spir and Cappuccino, the mammalian homologs Spir-1 and formin-2 show a regulatory
interaction. The interaction is mediated by a Spir-binding site at the very C-terminus of
formin-2 (formin-Spir-interaction site; FSI) adjacent to its core FH2 domain (Pechlivanis et al.,
2009). It has been shown that both mammalian Spir proteins, Spir-1 and Spir-2, interact with
each of the two formin proteins, formin-1 and formin-2 (Pechlivanis et al., 2009).
1.2.4 Other WH2-domain containing actin nucleation factors
Regulation of the actin cytoskeleton is mediated by the action of a vast number of actin-
binding proteins. A limited number of folding motifs mediate the interaction of actin-binding
proteins and actin, among which the b-thymosin/WH2 fold plays a prominent role (Paunola
et al., 2002, Dominguez, 2007, Dominguez and Holmes, 2010). WH2 domains are small actin
binding modules including 17-27 amino acids (Chereau et al., 2005, Paunola et al., 2002). They
contain the consensus motif L++V/T (+ representing basic amino acids) and a conserved N-
terminal amphiphilic helix, which mediates the binding to the hydrophobic pocket of actin.
Tb4, a short 43 amino acid polypeptide is the best-known member of the b-thymosin family.
It contains a long C-terminal extension, which extends along the nucleotide binding cleft of
actin and is important for the actin sequestration activity of Tb4 (Dominguez, 2007). WH2
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domains lack that C-terminal extension. If the b-thymosin and WH2 domains are evolutionary
related or evolved independently is still a matter of debate (Edwards, 2004, Dominguez, 2007).
Several WH2-domain containing actin nucleation factors were recently discovered, which have
the ability to nucleate actin filaments without the Arp2/3 complex.
The actin nucleation factor Cordon-bleu (Cobl) is a three-WH2-domain protein involved in
neural tube formation (Gasca et al., 1995, Carroll et al., 2003). Neuronal expression of the
C-terminal region, which contains the three WH2-domains, induces branches of the axons and
increases the number of dendrites (Ahuja et al., 2007).
Leiomodin-2 (Lmod-2) is another recently identifiedWH2-domain-containing actin nucleator
in muscle cells. Leiomodin nucleates unbranched actin filaments in vitro (Chereau et al.,
2008).
Moreover, two type-III secretion virulence factors of the pathogens Vibrio cholerae and
Vibrio parahaemolyticus, called VopF (Tam et al., 2007) and VopL (Liverman et al., 2007)
seem to use a Spir-like mechanism to nucleate actin. VopL and VopF, which are found to
be associated to actin structures in vivo, contain three WH2 domains and three copies of a
proline rich motif. Both factors alter the eukaryotic actin cytoskeleton. VopL induces stress
fibers (Liverman et al., 2007), whereas VopF induces aberrant actin-rich protrusions (Tam
et al., 2007). Otherwise, the type-III secretion factor TARP (translocated actin recruiting
phosphoprotein) from Chlamydia trachomatis, which also promoted actin nucleation in vitro,
contains only a single WH2 domain. It has been proposed that TARP oligomerizes to nucleate
actin (Jewett et al., 2006). These observations suggest that pathogens have adopted a Spir-like
actin nucleation mechanism to manipulate the host cytoskeleton.
1.3 Cellular vesicle transport
1.3.1 Spir function in vesicle transport processes
Targeting of cytosolic proteins to specific intracellular membranes is regulated by the specific
localization of different phospholipids. Several lipid binding domains are described which are
crucial for that lipid-mediated protein targeting (Lemmon, 2003).
DNA sequence comparisons of Spir-proteins revealed that the Spir C-terminus contains
a FYVE domain (named after the initial letters of four proteins containing a FYVE fin-
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ger: Fab1p, YOTB, Vac1p, EEA1) (Stenmark et al., 1996). FYVE domains are membrane
binding modules, consisting of a hydrophobic turret loop, which penetrates the membrane
(Kutateladze and Overduin, 2001, Psachoulia and Sansom, 2009). They have eight conserved
cysteines, which coordinate two Zn2+ions (Stenmark et al., 1996). FYVE domains are known
phospholipid interaction modules, which were subsequently identified as phosphatidylinositol
3-phosphat (PtdIns(3)P) binding domains (Gaullier et al., 1998, Patki et al., 1998, Burd and
Emr, 1998). The R(R/K)HHCRxCG motif between cysteine 2 and 3 is crucial for the binding
to PtdIns (3)P. Several proteins, like Rabphilin-3A have FYVE-related domains that lack sev-
eral conserved residues of FYVE fingers. Spir also contains a modified FYVE domain, lacking
the basic cluster between cysteines 2 and 3 and furthermore has a loop insertion between
cysteines 6 and 7.
The Drosophila Spire protein and Spir-1 show colocalization to Rab11 in transiently trans-
fected NIH3T3 mouse fibroblasts. Rab11 is implicated in the endocytic (Ullrich et al., 1996,
Goldenring et al., 1996, Calhoun et al., 1998) and the exocytic secretory pathway (Chen et al.,
1998, Wilcke et al., 2000, Urbe et al., 1993, Deretic, 1997). Furthermore, the localization
of Spir to membranes is dependent on the integrity of the FYVE domain and the Spir-box
(Kerkhoff et al., 2001). The expression of a truncated version of Spir-1 (Spir-1-CT), which
lacks the KIND domain and the 4 WH2 domains and therefore the ability to nucleate actin
filaments, inhibits the transport of vesicular stomatitis virus G protein (VSV-G) to the plasma
membrane (Kerkhoff et al., 2001), suggesting a role for Spir-1 in the secretory pathway.
Another study showed a possible role for Spir-1 in the endocytic pathway (Morel et al., 2009).
It has been shown, that the nucleation of actin patches on early endosomes is dependent on
annexin A2 and Spir-1, suggesting that actin nucleation is crucial for endosome biogenesis.
1.3.2 Regulation of vesicle transport processes
1.3.2.1 The Rab family of small G proteins (Ras-related in brain)
Rab small guanine nucleotide-binding proteins (G proteins) belong to the protein family of
Ras small G proteins. They serve as organizers of almost all membrane transport processes
in eukaryotic cells (Stenmark, 2009). Rab proteins and their effectors or regulators are highly
compartmentalized in organelle membranes, which is crucial for membrane identity. Like
other small G proteins, also Rab proteins circle between a GTP-bound active and a GDP-
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bound inactive conformation. However, there are a lot of other regulation factors identified
coordinating Rab activity (Ullrich et al., 1993, Alexandrov et al., 1994, Pfeffer et al., 1995,
Sivars et al., 2005, Dirac-Svejstrup et al., 1997, Soldati et al., 1994). Rab proteins are reversibly
associated with membranes by geranylgeranyl groups that are attached to one or two cysteine
residues at the C-terminus (Chavrier et al., 1991). The enzyme catalyzing this reaction is
Rab geranylgeranyltransferase (GGTase) (Casey and Seabra, 1996). A Rab Escort Protein
(REP) binds nonprenylated precursors directly after translation and presents them to the
GGTase (Alexandrov et al., 1994). Rab proteins are maintained in the GDP-bound inactive
conformation by GDP-dissociation inhibitors (GDIs) (Ullrich et al., 1993, Soldati et al., 1994).
Although, there are examples of Rab effectors that prefer the GDP-bound conformation
most effectors are activated only by the GTP-bound Rab protein (Seabra, 1996, Eathiraj
et al., 2005). Exchange of GDP with GTP is catalyzed by guanine nucleotide exchange factors
(GEFs) after displacement of the GDI, which is catalyzed by a GDI-displacement factor (GDF)
(Sivars et al., 2005). Rab proteins have an intrinsic GTPase activity but there are also GTPase-
activating proteins (GAPs), which could catalyze GTP hydrolysis to inactivate the GTPase
(Barr and Lambright, 2010, Bos et al., 2007). Together, GAPs, GDIs and REPs ensure that
Rab proteins are maintained in the inactive state in the cytosol so that activation occurs only
at the target membrane.
Rab11 There are three Rab11 isoforms: Rab11a, Rab11b and Rab11c/Rab25 (Bhartur et al.,
2000). Rab11a (Goldenring et al., 1996) and Rab11b (Lai et al., 1994) are ubiquitously ex-
pressed, whereas Rab25 has an epithelial restricted expression profile (Goldenring et al., 1993).
Rab11 has been detected on several subcellular membranes. It is associated with the pericen-
trosomal recycling system in nonpolarized (Ullrich et al., 1996, Ren et al., 1998) and polarized
cells (Goldenring et al., 1996, Lapierre et al., 2007, Calhoun et al., 1998). The recycling
endosome has a tubular morphology and its organization is dependent on the microtubule cy-
toskeleton. Internalized receptors, like the transferrin receptor, first enter the early endosome
(also called sorting endosome) then are transported to the recycling endosome (slow cycle) or
directly to the plasma membrane (fast cycle). It has also been shown that Rab11 mutants
modify the morphology of the recycling endosome and effect transferrin receptor transport
(Ullrich et al., 1996).
Rab11 is also localized to Golgi membranes (Urbe et al., 1993, Deretic, 1997, Chen et al.,
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1998). Expression of the dominant negative Rab11S25N mutant protein led to a significant
inhibition of the transport from the trans-Golgi network (TGN) to the plasma membrane of
the VSV-G protein, resulting in an accumulation of the VSV-G protein in the Golgi (Chen
et al., 1998). This suggests that functional Rab11 is required for efficient export of VSV-G
protein from the Golgi. GDI proteins are frequently be used to alter the membrane association
of Rab proteins. Overexpressing of GDIs leads to a release of Rab11-GDP from membranes.
It has been shown that an excess of GDI proteins causes an inhibition in membrane transport
from the trans-Golgi network to the plasma membrane (Chen et al., 1998). Furthermore, a
role for Rab11a in retrograde traffic has also been observed, where it regulates the exit of
membranes from the recycling endosome (Wilcke et al., 2000).
Small G proteins of the Rab11 family, including Rab11a and Rab25 have an effect of migra-
tion and invasion of tumor cells. It has been shown that Rab11a and Rab25 control recycling
of internalized a5ß1 integrin (Roberts et al., 2001, Caswell et al., 2007, 2008). Elevated levels
of Rab25 in ovarian and breast cancer cell lines participate in tumor progression by increas-
ing tumor growth and aggressiveness of already transformed tumor cells (Cheng et al., 2004,
Agarwal et al., 2009). Rab11 family-mediated recycling of multiple factors could therefore
collectively contribute to tumor pathogenesis.
Rab11a/myosin Vb cooperation The motorprotein myosin V has been implicated in or-
ganelle trafficking along actin filaments. To ensure the correct targeting of the motorprotein
to specific vesicles or organelles, Rab G proteins have been identified as important regulators
of myosin V recruitment. Rab27a recruits myosin Va to melanosomes via the adaptor protein
melanophilin (Wu et al., 2001). Mutations in the Rab27a, melanophilin or the myosin Va gene
result in a disease called Griscelli syndrome (Fukuda, 2005). Griscelli syndrome is defined by
the characteristic hypopigmentation (albinism) and variable immunodeficiencies due to defects
in the transport of melanosomes in melanocytes and lytic granules in cytotoxic T-lymphocytes
(Griscelli and Prunieras, 1978). Another important cooperation between a Rab G protein and
a myosin V motor is the recruitment of myosin Vb to recycling endosomes by Rab11 (Volpicelli
et al., 2002, Fan et al., 2004, Hales et al., 2002, Swiatecka-Urban et al., 2007). Overexpression
of the tail domain of myosin Vb leads to an accumulation of Rab11a in recycling endosomes
(Lapierre et al., 2001). Furthermore, it has been shown, that the Rab11-binding protein
FIP2 is involved in the recruitment of myosin Vb by binding to its tail domain (Hales et al.,
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2002, Lapierre et al., 2001). Myosin Vb is enriched in the hippocampus (Zhao et al., 1996)
and it has been shown that myosin Vb together with Rab11/Rab11-FIP2 mediates Ca2+-
dependent, actin-based transport of AMPA receptor containing recycling endosomes during
(LTP). Myosin Vb motor activity and myosin Vb-binding to Rab11/Rab11-FIP2 is required
for AMPA receptor insertion and spine growth and thus synaptic potentiation (Wang et al.,
2008).
Rab11 FIP family proteins Consistent with the role of Rab11 in several membrane traffic
pathways, many Rab11-interacting proteins have been identified (Wallace et al., 2002). There
are six novel Rab11-interacting proteins belonging to a family of proteins called family of
Rab11-interacting proteins (FIPs). All FIPs contain a highly conserved Rab binding domain
(RBD) at their C-termini. Another feature of all FIPs is their a-helical coiled coil domain
at the C-terminus, which is crucial for their homo- and hetero-interacting abilities (Wallace
et al., 2002). Based on sequence homology, all FIPs can be divided into three classes. Rip11,
FIP2 and RCP (Rab coupling protein) are class I FIPs. They all contain a C2 domain at the
N-terminus. FIP3/Eferin and FIP4 (Wallace et al., 2002), which are containing EF-hands,
belong to class II. The only member of class III is FIP1. FIP1 is the only Rab11-interacting
protein, which lacks any N-terminal structural domains (Fig. 1.2).
FIP proteins do not require Rab11 for membrane binding (Meyers and Prekeris, 2002).
Overexpression of the dominant negative mutant Rab11S25N had no effect on the localization
of endogenous FIP2, Rip11 and FIP3 (Meyers and Prekeris, 2002). This raises the possi-
bility that FIPs may target Rab11 to defined membrane structures in the cell. In this way
Rab11-FIPs could play a role as Rab11 scaffolding proteins. Rab11/FIP complexes at specific
membrane compartments could than recruit other proteins, such as motor proteins or Arf
proteins (Shin et al., 1999, 2001, Shiba et al., 2006, Hales et al., 2002, Lapierre et al., 2001).
FIP2, a member of class I FIPs, contains a N-terminally located C2 domain. C2 domains
are implicated in phospholipid binding and protein-protein interaction. It has been shown,
that the C2 domain of FIP2 binds preferentially to phosphatidylinositol 3,4,5-trisphosphate
(PtdIns(3,4,5)P3) and phosphatidic acid (PA), suggesting that the C2 domain targets FIP2
to PtdIns(3,4,5)P3 and PA-enriched membranes (Lindsay and McCaffrey, 2004). Expression
of truncation mutants of FIP2 that lack their C2 domains leads to inhibition of endsomal
recycling traffic and causes tubulation of the transferrin receptor (TfR)-positive endosomal
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compartments (Lindsay et al., 2002, Lindsay and McCaffrey, 2002, Prekeris et al., 2000).
Figure 1.2: Domain structure of different Rab11-FIPs
RCP, Rip11 and FIP2 belong to class I Rab11-FIPs. They contain a C2 domain near their
N-termini and the highly conserved 20 amino acid RBD (Rab Binding Domain) at their C-
termini. The second class comprises FIP3 and FIP4, both containing EF hand motifs and an
ERM domain. Class III contains just one member, FIP1, which does not have either a C2
domain nor EF hand domains.
Figure adapted from Wallace et al., 2002.
Basolateral transport of E-cadherin is Rab11-dependent Cells in epithels are connected
by so called adherens junctions consisting of protein complexes. The major components are
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cadherins, transmembrane proteins, which mediate cell-cell adhesion in a Ca2+-dependent
manner. The extracellular region of cadherins mediates the homotypic binding to a cadherin
protein of an adjacent cell, whereas the cytoplasmic region binds to intracellular proteins, like
ß-catenin.
E-cadherin, the epithelial cadherin, is trafficked and delivered to the basolateral cell surface.
It is transported from the TGN to the plasma membrane by passing endosomal structures
(Lock and Stow, 2005, Desclozeaux et al., 2008). By using GFP-tagged E-cadherin it has
been shown that this transport is mediated by tubulovesicular carriers (Lock and Stow, 2005,
Lock et al., 2005). Furthermore, Rab11-positive compartments are traversed by E-cadherin
on its route to the plasma membrane. These studies demonstrated a Rab11-positive recycling
endosome as an intermediate compartment for post-Golgi exocytosis of E-cadherin in HeLa
cells. Overexpression of Rab11 results in an increased intracellular E-cadherin localization
and a reduced cell surface delivery of E-cadherin supporting a functional role for Rab11 in
E-cadherin trafficking (Lock and Stow, 2005).
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2 MATERIALS
2.1 Expendable items
Item Manufacturer Order number
Autoclave tape (180°C)
distributed by A. Hartenstein
Laborbedarf
STKH
Autoclave tape (120°C)
distributed by A. Hartenstein
Laborbedarf
STKD
Blotting papers Grade 3 MM
Chr
Whatman 3030.917
Cell culture flask T75 red cap Sarstedt 83.1813.002
cell culture plates 6-Well Greiner Bio-One 657160
Cell culture glass bottom dish Willco wells GWSt-5040
Conical reaction tubes (15
ml)
Greiner Bio-One 188271
Conical reaction tubes (50
ml)
Greiner Bio-One 227261
Cryovials (1 ml) Thermo-Scientific, Nunc 366656
Embedding cassette Carl-Roth E478.1
Microscope cover glasses (15
mm diameter)
Marienfeld Laboratory
Glassware
0111550
Microscope slides
SuperFrost® Plus
Menzel, Thermo Scientific J1800AMNZ
Neubauer counting chamber Brand
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Nitrocellulose transfer
membrane, PROTRAN®
BA85, 0.45 µM pore size
Whatman 10401196
Parafilm® M Laboratory
Film
Pechiney Plastic Packaging PM-996
Pasteur pipettes
distributed by A. Hartenstein
Laborbedarf
PP07
PCR-tubes (0.2 ml)
Axygen, distributed by
Abimed
PCR-0208-CP-C
Petri dishes (94 x 16 mm)
distributed by A. Hartenstein
Laborbedarf
PP90
Pipette tips (0.5-10 µl)
Axygen, distributed by
Abimed
T-300
Pipette tips (100-1000 µl)
Axygen, distributed by
Abimed
T-1000-B
Pipette tips (2-20 µl) and
(20-200 µl)
Sarstedt 70.760.002
PIP StripsTM membranes
-set of 10-
Invitrogen P23751
Reaction tubes (1.5 ml)
distributed by A. Hartenstein
Laborbedarf
RK1G
Reaction tubes (2.0 ml)
distributed by A. Hartenstein
Laborbedarf
RK2G
Scalpel Megro 147222
Slide-A-Lyzer* Dialysis
Cassettes, 10K MWCO, 0,5
ml
Thermo-Scientific 66383
Syringe (1 ml) with needle
0.45 x 10 mm
Becton-Dickinson 300015
Syringe (10 ml) Braun 4606108V
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Syringe (50 ml) Dispomed 22050
Syringe filter (0.2 µm) Sartorius Stedim Biotech 17597
X-ray film FujiFilm 47410 08379
2.2 Chemicals
Item Manufacturer Order Number
Agar select Sigma-Aldrich A5054
Acrylaminde (30%)/
Bisacrylamide (0,8%) (37.5:1)
Carl-Roth 3029.1
Agarose, UltraPure Invitrogen, Molecular Probes 15510-027
Ammonium persulfate (APS) Sigma-Aldrich A3678
Ampicillin; Sodium
crystalline
Sigma-Aldrich A9518
BCP, phase separation
reagent
MRC Molecular Research
Center, Inc.
BP151
ß-Mercaptoethanol Carl-Roth 4227.3
Boric acid Sigma-Aldrich B0252
Bovine serum albumin, Cohn
V fraction
Sigma-Aldrich A4503
Bromophenol blue Carl-Roth A512.1
Calcium chloride Carl-Roth A119.1
Chloramphenicol Sigma-Aldrich C0378
Complete, Mini, EDTA-free;
Proteaseinhibitor
Roche 11836170001
Coomassie Blue G Carl-Roth 9598.1
Diethyl Pyrocarbonate
(DEPC)
Sigma-Aldrich D5758
Dimethyl Sulfoxide (DMSO) Sigma-Aldrich D2650
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ECL reagent GE/Healthcare RPN2109
EDTA Sigma-Aldrich E5134
Ethanol >99.8%, p.a. Carl-Roth 9065.2
Ethanol denatured (+1%
Mek)
Carl-Roth K928.1
Ethidiumbromide Carl-Roth HP46.1
Fetal bovine serum Fetalclone
III
Thermo Scientific; Hyclone SH30109.03
Glutathione Sigma-Aldrich G4251
Glutathione agarose beads GE/Healthcare 17-0756-01
Glycerine Carl-Roth 3783.1
Glycerine solution (for
microscopy)
Leica 11513872
Glycine Sigma-Aldrich G7126
Hydrochloric acid Carl-Roth 6331.1
Imidazole Sigma-Aldrich I0125
IPTG Sigma-Aldrich I9003
Isopropanol AppliChem A0900
Kanamycin Sigma-Aldrich K-1377
LB Sigma-Aldrich L3022
Lipofectamine Invitrogen, Molecular Probes 18324012
Magnesium chloride
hexahydrate
Carl-Roth 2189.2
Methanol 99.9% Carl-Roth 4627.2
Milk powder, blotting grade Carl-Roth T145.2
Mowiol Calbiochem 475904
Ni-NTA Agarose Qiagen 30210
Nitric acid Carl-Roth 4989.1
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Nonidet P-40
Biochemica; distributed by
A. Hartenstein Laborbedarf
A1694,0500
Paraformaldehyde (PFA) Carl-Roth 0335.1
PBS buffer (10X Dulbecco's)
 powder
AppliChem A0965
Phalloidin Rhodamine Invitrogen, Molecular Probes R415
Ponceau S Sigma-Aldrich P3504
Protein-G-Agarose beads Roche 11 243 233 001
Rubidium chloride Carl-Roth 4471.1
Sodium chloride Sigma-Aldrich S3014
Sodium citrate tribasic
dihydrate
Sigma-Aldrich S4641
Sodium dodecyl sulfate (SDS) Sigma-Aldrich L4390
Sodium hydroxide pellets Merck 106462
Sodium phosphate Sigma-Aldrich S9638
TEMED Sigma-Aldrich T9281
Triton X 100 Carl-Roth 3051.3
Trizol® Reagent Invitrogen, Molecular Probes 15596026
Tween 20 AppliChem A1389
2.3 Kits
Kit Manufacturer Order number
NucleoTrap DNA Gel
extraction Kit
Macherey-Nagel 740609.50
DNA Plasmid Maxi Kit Qiagen 12163
DNA Plasmid Mini Kit Qiagen 12123
QuantiTect Reverse
Transcription
Qiagen 205311
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One-Step RT-PCR Qiagen 210212
2.4 Bacterial strains
Strain Manufacturer Annotation Order number
NEB10ß NEB
Genotype: araD139 ∆(ara,leu)7697 fhuA
lacX74 galK16 galE15 mcrA
f80d(lacZ∆M15) recA1 relA1 endA1 nupG
rpsL rph spoT1∆(mrr hsdRMS mcrBC)
C3019H
E. coli
Rosetta
Novagen /
Merck
Increased protein expression rate by
providing tRNAs rarely used in E. coli
Genotype: F- ompT hsdSB(rB- mB-) gal
dcm pRARE (CamR)
70953
2.5 Cultured cell lines
Cell line ATTC number Annotation
HeLa CCL-2
an immortal cell line derived
from cervical cancer cells
taken from Henrietta Lacks
HEK 293 CRL-1573
human embryonic kidney 293
cells
MDCK CCL-34
Madin-Darby canine kidney
epithelial cell line
MDCK Myc-hs-Spir-2
stable cell line
pBABE-puro vector provides
retrovirus sequences for the
delivery of exogenous genes
in mammalian cells
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2.6 Expression vectors
Vector Manufacturer annotation
pGEX-4T-3 GE/Healthcare
Bacterial expression vector
Genes cloned into the MCS will be expressed as
fusions to the C-terminus of GST
pProEX HTb
Invitrogen,
Molecular Probes
Bacterial expression vector
Genes cloned into the MCS will be expressed as
fusion proteins with an N-terminally 6xHis tag
pEGFP-C1 Clontech
Mammalian expression vector
Genes cloned into the MCS will be expressed as
fusions to the C-terminus of eGFP
pEGFP-N3 Clontech
Mammalian expression vector
Genes cloned into the MCS will be expressed as
fusions to the N-terminus of eGFP
mStrawberry
kindly provided
by A. Akhmanova
Mammalian expression vector
EGFP-C2 backbone (Clontech) eGFP substituted
against mStrawberry
Genes cloned into the MCS will be expressed as
fusions to the N-terminus of the mStrawberry protein
pcDNA3
Invitrogen,
Molecular Probes
Mammalian expression vector
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2.7 Enzymes
Item Manufacturer Order number
BioTerm Taq-Polymerase Genecraft GC-002-0500
10x BioTherm buffer 15 mM
MgCl2
Genecraft GC-002-006
Pfu-Polymerase Promega M774B
Pfx -Polymerase/Accuprime Invitrogen, Molecular Probes 12344024
Phusion-High-Fidelity DNA
Polymerase
NEB F530S
Restrictionenzymes NEB
T4 DNA ligase (supplied
with 10X Reaction Buffer)
NEB M0202
2.8 Molecular Weight Standards
Item Manufacturer Order number
DNA ladder 1 kb peqLab 25-2031
DNA ladder 100 bp peqLab 25-2010
Precision Plus Protein dual
color standard
Bio-Rad 1610374
2.9 Cell culture media and supplements
Item Manufacturer Order number
DMEM Invitrogen, Molecular Probes 41965039
HEPES buffer
1 mM
Invitrogen, Molecular Probes 15630056
L-Glutamine 200 mM Invitrogen, Molecular Probes 25030024
Poly-L-Lysine; 0,01% solution Sigma-Aldrich P 4707
Trypsin 0,05% EDTA Invitrogen, Molecular Probes 25300054
PBS Invitrogen, Molecular Probes 14190094
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2.10 Antibodies
2.10.1 Primary antibodies
Antigen Name Species Order number Manufacturer
Anti-myc Myc 9E10
mouse
monoclonal
sc-40 Santa Cruz
E-cadherin DECMA-1 rat monoclonal sc-59778 Santa Cruz
Anti-His
penta-His-
Antibody
mouse
monoclonal
34660 Qiagen
Anti-alpha-
Tubulin
alpha-Tubulin
Antibody
mouse
monoclonal
A-11126
Invitrogen,
Molecular Probes
Anti-ERK1 ERK1 (C-16) rabbit polyclonal sc-93 Santa Cruz
Anti-EGFP
Living-colors
EGFP A.v.
Peptide Antibody
rabbit polyclonal 632376 Clontech
Anti-dsRed
Living-colors
dsRed A.v.
Peptide Antibody
rabbit polyclonal 632496 Clontech
Anti-GST anti-GST goat monoclonal 27-4577-01 GE Healthcare
2.10.2 Secondary antibodies
Antigen Name Species Order number Manufacturer
Anti-mouse
Flourescin
(FITC)-
conjugated
AffiniPureDonkey
anti-mouse IgG
donkey polyclonal 715-095-151
Jackson Immuno
Research
Laboratories
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Anti-mouse
Rhodamine
(TRITC)-
conjugated
AffiniPureDonkey
anti-mouse IgG
donkey polyclonal 715-025-151
Jackson Immuno
Research
Laboratories
Anti-rat
Rhodamine
(TRITC)-
conjugated
AffiniPureDonkey
anti-rat IgG
donkey polyclonal 712-025-153
Jackson Immuno
Research
Laboratories
Anti-mouse
Cy5-conjugated
AffiniPureDonkey
anti-mouse IgG
donkey polyclonal 715-175-151
Jackson Immuno
Research
Laboratories
Anti-mouse
anti-mouse IgG
horseradish-
peroxidase linked
sheep polyclonal NA 9310
Amersham
Pharmacia
biotech
Anti-rabbit
anti-rabbit IgG
horseradish-
peroxidase linked
sheep polyclonal NA 9340
Amersham
Pharmacia
biotech
Anti-rat
anti-rat IgG
horseradish-
peroxidase linked
sheep polyclonal NA 932
Amersham
Pharmacia
biotech
Anti-goat
bovine anti-goat
IgG horseradish-
peroxidase linked
sc-2350 Santa Cruz
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2.11 Buffers and solutions
Acrylamid Gel electrophoresis (Protein SDS-PAGE)
Separating Gel
6,5 % 7,5 % 10 % 12 %
H2O dest 20,2 ml 17,1 ml 14,5 ml 12,3 ml
3M Tris-HCl
pH 9,0
3,8 ml 3,8 ml 3,8 ml 3,8 ml
Acrylamid Roti
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6,8 ml 7,9 ml 10,5 ml 12,7 ml
20 % SDS 0,15 ml 0,15 ml 0,15 ml 0,15 ml
TEMED 0,03 ml 0,03 ml 0,03 ml 0,03 ml
10 % APS 0,15 ml 0,15 ml 0,15 ml 0,15 ml
Stacking Gel
H2O dest 7,7 ml
1M Tris-HCl pH 6,8 1,25 ml
Acrylamid Roti 30 1,66 ml
20 % SDS 0,05 ml
TEMED 0,015 ml
10 % APS 0,1 ml
Co-immunoprecipitation buffer with EDTA
 25 mM Tris-HCl pH 7,4
 150 mM NaCl
 10 % (v/v) Glycerin
 0,1 % NP-40
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Co-immunoprecipitation buffer without EDTA (G proteins, myosin Vb)
 25 mM Tris-HCl pH 7,4
 150 mM NaCl
 2,5 mM MgCl2
 1 mM DTT
 10 % (v/v) Glycerin
 0,1 % NP-40
1x DNA sample buffer
 9 mM Tris-HCl pH 7,4
 0,45 mM EDTA
 46 % (v/v) Glycerin
 0,2 % (w/v) SDS
 0,05 % (w/v) Bromophenolblue
10x Electrophoresis buffer (Protein SDS-PAGE)
 250 mM Tris
 190 mM Glycin
 0,1 % (w/v) SDS
 H2O dest.
 pH 8,6
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Elution buffer (Purification of 6xHis-tagged proteins)
 50 mM NaH2PO4
 300 mM NaCl
 250 mM Imidazol
 pH 8,0
Elution buffer without phosphat (Purification of 6xHis-tagged proteins;
protein-lipid overlay assay)
 50 mM Tris-HCl
 500 mM NaCl
 250 mM Imidazol
 pH 8,0
Lysis buffer
 50 mM NaH2PO4
 300 mM NaCl
 10 mM Imidazol
 pH 8,0
Elution buffer (Purification of GST-tagged proteins)
 50 mM Tris
 200 mM NaCl
 25 mM Glutathione
 pH 8,8
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5 % Milk solution (blocking reagent)
 5 % (w/v) milk powder in PBST
Mowiol solution
 15 % (w/v) Mowiol
 30 % (v/v) Glycerin
 2,25 % (w/v) N-propyl gallate in 1x PBS
1x PBS
 9,55 g 10x Dulbecco's PBS powder in 1 l H2O dest
PBST
 0,05 % (v/v) Tween 20 in 1x PBS
Pull down buffer
 25 mM Tris-HCl pH 7,4
 300 mM NaCl
 1 mM EDTA
 0,1 % (v/v) NP-40
 10 % (v/v) Glycerin
Rubidium chloride buffer
RFI
 100 mM RbCl
 30 mM KAc
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 10 mM CaCl2
 15 % (v/v) Glycerin
 pH 5,8
RFII
 10 mM MOPS
 10 mM RbCl
 75 mM CaCl2
 15 % (v/v) Glycerin
 pH 6,8
1x SDS sample buffer (Protein sample buffer)
 60mM Tris-HCl pH 6,8
 10 % (v/v) Glycerin
 3 % (w/v) SDS
 5 % (v/v) b-Mercaptoethanol
 0,005 % (w/v) Bromophenolblue
5x SDS sample buffer (Protein sample buffer)
 300 mM Tris-HCl pH 6,8
 50 % (v/v) Glycerin
 15 % (w/v) SDS
 25 % (v/v) b-Mercaptoethanol
 0,025 % (w/v) Bromophenolblue
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Stripping buffer
 62,5 mM Tris
 2 % (w/v) SDS
 pH 6,7
10x TBE buffer (DNA electrophoresis)
 890 mM Tris
 89 mM Boric acid
 20 mM EDTA
TBST (Purification of GST-tagged proteins; protein-lipid overlay assay)
 10 mM Tris-HCl pH 7,4
 150 mM NaCl
 0,1 % (v/v) Tween 20
Washing buffer (Purification of 6xHis-tagged proteins)
 50 mM NaH2PO4
 300 mM NaCl
 20 mM Imidazol
 pH 8,0
Western blotting buffer (WB)
 190 mM Glycine
 125 mM Tris base
 20 % methanol (v/v)
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3 METHODS
3.1 Molecular Biological Methods
3.1.1 Cloning strategy
3.1.1.1 Amplification of a gene of interest
Reverse transcription PCR (RT-PCR)
The RT-PCR method is used to translate RNA to its DNA complement (complementary DNA,
or cDNA) by using the enzyme reverse transcriptase. The cDNA is then amplified using a
traditional PCR with a DNA polymerase. Three different types of primers could be used for
the RT-step: random primers, oligo (dT) primers or gene specific primers.
There are two ways to perform a RT-PCR, first the RT-step could be performed in the
same reaction tube like the following PCR-step (one-step RT-PCR). On the other hand, the
PCR-step could be performed in another reaction tube (two-step RT-PCR).
DNA amplification (PCR)
To generate a DNA insert for cloning into a specific vector, the gene of interest must be
amplified by using PCR. It is recommended to use a DNA polymerase, which possesses a
proofreading ability, like Pfu or Pfx polymerases. The used primer pair must include restriction
sites, which are required for the later digestion of the DNA insert and the cloning vector. The
resulting DNA fragment contains specific restriction sites on both ends.
3.1.1.2 DNA recovery from agarose gels
Following the DNA amplification step, the PCR reaction was loaded on a 0,8 % agarose gel
and electrophoretic separated. DNA fragments of interest were excised and recovered from the
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gel by using the NucleoTrap Gel Extract Kit (Macherey & Nagel) following the manufacturers
instructions.
3.1.1.3 DNA digestion
The cloning vector and the DNA fragment, which contain specific restriction sites, were incu-
bated with restriction endonucleases (NEB) following the manufacturers instructions. Correct
digestion was verified by agarose gel electrophoresis. The DNA fragment and the cloning vec-
tor were then recovered from the gel by using the NucleoTrap Gel Extract Kit (Macherey &
Nagel).
3.1.1.4 Ligation
After generation and purification of DNA insert and cloning vector, both were eluted together
in 1x T4 ligase buffer and T4 DNA ligase (NEB). The optimal molar ratio between insert and
vector should be 3:1 to maximize the ligation rate. The optimal temperature for the T4 ligase
is 16 °C. The ligation reaction was performed over night and the total reaction was used for
transformation in competent cells.
3.1.1.5 Transformation
Transformation is the process of uptake of exogenous plasmid DNA into a bacterium. Bacteria
that are capable of being transformed are called competent. Competent cells are prepared
by treatment with rubidium chloride (RbCl). Cells are treated with a hypotonic solution
containing RbCl. It increases the ability of a prokaryotic cell to incorporate plasmid DNA
allowing them to be genetically transformed. The addition of rubidium chloride to a cell
suspension promotes the binding of plasmid DNA to the cell surface, which can then pass into
the cell.
The ligation reaction (see 3.1.1.4) was added to 100 µl competent E. coli (NEB10ß) cells,
previously thawed on ice, gently mixed and incubated on ice for further 40 minutes. After-
wards, cells were heat shocked for 90 seconds at 42 °C and chilled on ice for 3 minutes. 500 µl
LB was added and the cells were incubated under shaking for 1 hour at 37 °C. Subsequently,
cells were harvested by centrifugation at 4000 rpm for 3 minutes at room temperature. The
supernatant was discarded and the pellet was resolved in 150 µl H2O. 50 and 100 µl were
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plated out on LB agar plates containing the appropriate antibiotic. Plates were incubated
overnight at 37 °C.
3.1.1.6 DNA purification
For subsequent plasmid purification, transformed E. coli clones were picked from the LB agar
plate and inoculated over night in LB supplemented with the appropriate antibiotic at 37
°C with shaking. Finally, cells were pelleted and plasmid DNA was isolated employing the
Plasmid Mini Kit or the Plasmid Maxi Kit (Qiagen). To verify the correct insertion of the
DNA into the specific vector an average of 10 clones were picked and inoculated to perform
a plasmid mini DNA preparation of each clone. The purified DNA was digested with the
particular restriction enzymes, which are used for the cloning. The digested DNA was loaded
on a 0,8 % agarose gel to verify the correct insert. The positive clone could than be used to
perform a maxi DNA preparation.
3.1.1.7 Sequencing
DNA plasmids were sequenced by Eurofins MWG/Operon (Ebersberg)
3.1.2 Constructs designed for this study
pEGFP-N3-hs-Arf1 The hs-Arf1 (NCBI ID: NM_001024227.1) cDNA was generated by us-
ing mRNA from human cerebellum (kindly provided by the Institute of Pathology, University
Hospital Regensburg). The Qiagen OneStep RT-PCR Kit was used. The PCR-fragment (546
bp) was digested with KpnI/BamHI and cloned into pEGFP-N3 linearized with KpnI/BamHI.
The sequence was confirmed by DNA sequence analysis at MWG. Due to the fact, that Arf
proteins are modified at their N-terminus it is recommended to use a C-terminally located tag.
Therefore the pEGFP-N3 vector was used.
pEGFP-C1-hs-Rab11-FIP2 The Rab11-FIP2 cDNA (NCBI ID: NM_014904) was generated
by employing human cerebellum mRNA. The Qiagen OneStep RT-PCR Kit was used. The
RT-PCR-fragment (1539 bp) was digested with EcoRI/BamHI and cloned into pEGFP-C1
linearized with EcoRI/BamHI. Using the pEGFP-C1 vector the Rab11-FIP2 protein will be
N-terminally tagged.
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mStrawberry-hs-MyoVb-cc-tail The hs-MyoVb-cc-tail sequence (NCBI ID: NM_001080467)
was subcloned from the pFAST -BacHT-AM5BHMM vector (kindly provided by Mitsuo Ikebe)
into the mStrawberry vector. The used mStrawberry vector has a pEGFP-C2 backbone, in
which the eGFP sequence is substituted against the strawberry sequence (the mStrawberry-
Rab6a vector was kindly provided by Anna Akhmanova). The PCR-fragment (3820 bp) di-
gested with HindIII/XbaI cloned into mStrawberry-Rab6a linearized with HindIII/XbaI. Using
the pEGFP-C2 vector the MyoVb-cc-tail protein will be N-terminally tagged.
pcDNA3-Myc-hs-Spir-2-DKW The hs-Spir-2-DKW sequence (NCBI ID: AJ422077.1) was
subcloned from the pcDNA3 -Myc-hs-Spir-2 vector into the pcDNA3 vector (Invitrogen). To
add a Myc-epitope tag on the hs-Spir-2-DKW sequence the 5' primer contains the Myc epi-
tope sequence. The PCR-fragment (1060 bp) was digested with BamHI/EcoRV cloned into
pcDNA3 linearized with BamHI/EcoRV. Using the pcDNA3 vector the Spir-2 protein will be
N-terminally tagged.
pGEX-4T-3-hs-Spir-2-DKW The hs-Spir-2-DKW sequence was subcloned from the pProEX
HTb-hs-Spir-2-DKW vector. The hs-Spir-2-DKW insert was digested from pProEX HTb-hs-
Spir-2-DKW by using BamHI/XhoI and cloned into pGEX-4T-3 linearized with BamHI/ XhoI.
The GST-tag will be at the N-terminus of the Spir-2 protein.
pProEX HTb-mm-Spir-1-DKW The Spir-1-DKW cDNA (NCBI ID: NM_176832) was gen-
erated by employing mouse brain mRNA. The Qiagen OneStep RT-PCR Kit was used. The
RT-PCR-fragment (1068 bp) digested with NcoI/XhoI cloned into pProEX HTb linearized
with NcoI/XhoI. Using the pProEX HTb vector the Spir-1 protein will be N-terminally tagged.
Supplemental table II summarizes the individual constructs, provides a description of the frag-
ment boundaries and their purpose.
3.2 Protein Biochemical Methods
3.2.1 Electrophoretic protein separation
Polyacrylamide gel electrophoresis (PAGE) is used to separate proteins according to their
electrophoretic mobility. Due to the fact that proteins are amphoteric compounds, their net
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charge is determined by the pH of the solution. Throughout the course of this work protein
samples were separated under denaturing conditions by using the anionic detergent sodium
dodecyl sulfate (SDS). SDS disrupts the secondary and tertiary structure and confers a negative
charge to the polypeptides in proportion to their length.
Protein samples were loaded on a discontinuous system, in which the tank and gel buffers
are different from each other. A non-restrictive large-pore gel, called a stacking gel, overlays
a smaller pore resolving gel. Prior to loading, protein samples were boiled in 1x- or 5x SDS
sample buffer for 6 minutes at 95 °C. Protein sizes were analyzed using the prestained Protein
Ladder (Bio-Rad) as a molecular mass marker. Electrophoresis was performed at 45 mA at
room temperature until the bromophenol blue dye reached the bottom of the gel.
To stain protein bands directly after the separation via SDS-PAGE, Coomassie staining
solution was used. The acrylamide gel was boiled in Coomassie staining solution for 1-2
minutes. After that, the gel was boiled 3-4 times in H2O dest. and washed with H2O dest. by
gently agitation.
3.2.2 Western Blot and immunodetection
Separated proteins were transferred to a nitrocellulose membrane by electroblotting using a
Sigma blotting tank. The transfer was performed for 1,5 hours at 150 mA at room temperature
in Western blotting buffer. To verify the protein transfer the nitrocellulose was stained with
Ponceau S solution (Sigma-Aldrich). The nitrocellulose was incubated in Ponceau S solution
for 2 minutes at room temperature and washed with H2O 3-5 times with shaking. To destain
the nitrocellulose, PBST was used.
For immunodetection the nitrocellulose membrane was blocked in 5 % milk solution over
night at 4 °C. After blocking the nitrocellulose was incubated in milk solution containing the
particular primary antibody for 1-2 hours. Adjacent to the incubation with the primary anti-
body, the nitrocellulose was washed three times with PBST at room temperature with shaking
for ten minutes. Subsequently, the nitrocellulose was incubated in a milk solution/PBST so-
lution (1:3 ratio) containing the secondary horseradish peroxidase (HRP)-linked antibody for
30-45 minutes at room temperature with shaking. After the second antibody incubation step
the nitrocellulose was washed three times for ten minutes at room temperature. Finally, the
HRP-coupled secondary antibody was detected with an ECL reagent kit (enhanced chemo-
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luminescence, Amersham). The light signal was detected by autoradiography using a x-ray
film.
3.2.3 Western Blot stripping
Membrane stripping is the removal of antibodies (including primary and secondary) from a
western blot membrane, to allow the further incubation of the membrane with other primary
and secondary antibodies.
The membrane was incubated with prewarmed 50 ml Stripping buffer (ß-mercaptoethanol
was freshly added) at 60 °C for 15 minutes. That incubation step was repeated 3 times. After
the third incubation, the membrane was washed with PBST four times for 10 minutes at room
temperature.
3.2.4 Protein expression in prokaryotes
For the expression of recombinant proteins, the E. coli strain Rosetta (Novagen) was used.
The Rosetta strain contains a pRARE plasmid (chloramphenicol resistence) coding for tRNAs
of the rarely used codons Arginine, Isoleucine, Glycine, Leucine and Proline, resulting in an
increased protein expression rate. Protein expression is under the control of the lacZ promotor
and is induced by the lactose analog isopropyl-b-D-thio-galactoside (IPTG). IPTG binds to the
repressor and inactivates it, but is not a substrate for b-galactosidase. As it is not metabolized
by E. coli, its concentration remains constant. Therefore the expression rate of the recombinant
protein is also constant.
3.2.5 Ni-NTA based purification of 6xHis-tagged recombinant proteins
6xHis-tagged proteins could efficiently be purified by using nickel-nitrilotriacetic acid (Ni-NTA)
metal-affinity chromatography matrices. The histidine residues of the recombinant protein of
interest bind specific to the Ni-NTA matrix allowing the purification of proteins from bacterial
lysates and the accumulation of these proteins in a large scale. For the expression of 6xHis-
tagged proteins the pProEX HTb vector system was used. The 6xHis-tag is added to the
N-terminus of the specific protein.
Procedure for 500 ml of a bacterial culture:
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 Culture growth:
50 ml of LB medium containing 10 % ampicillin (1:1000) and chloramphenicol (34
mg/ml) (1:1000) were inoculated over night at 37 ºC with continuous shaking. At the
next day 500 ml of LB medium containg 10 % ampicillin (1:1000) and chloramphenicol
(34 mg/ml) (1:1000) were inoculated 1:10 with the noninduced overnight culture. The
culture grew at 37 ºC with shaking until an OD600 of 0,5 was reached. The temperature
was lowered to 21 - 25 ºC and after on OD600 of 0,6 was reached the expression was
induced by adding IPTG to a final concentration of 0,1 mM. The culture was incubated
overnight at 21 - 25 ºC. One 500 µl sample was taken immediately before the induction
(noninduced control t0), whereas another 500 µl sample was taken 2 hours after the
induction and at the second day (induced control tI). The cells were harvested by cen-
trifugation (Beckman Coulter; Avanti J26XP -> JA14 rotor) at 13000 rpm, 30 minutes,
4 ºC and pellets were frozen at -20 ºC.
 Protein extraction:
The cell pellet was thawed on ice and resuspended in lysis buffer at 2-5 ml per gram
wet weight. The cell lysate was sonificated 16x 10 seconds 80-100 % and centrifuged
(Beckman Coulter; Avanti J26XP -> JA25.50 rotor) at 15000 rpm at 4 ºC for 30 minutes.
The cleared lysate was saved and a sample of 40 µl was taken (soluble protein fraction).
The pellet was resuspended in 5-10 ml lysis buffer and 20 µl were taken for the insoluble
protein control (pellet). Proteins were purified by using a batch purification method
under non-denaturing conditions. Ni-NTA beads (Qiagen) were washed two times with
washing buffer and added to the cleared lysate. The cleared lysate and the Ni-NTA
agarose beads were then rotated for 1-2 hours at 4 ºC on a rotator. Two additional
controls were taken to control the binding of the 6xHis-tagged protein to the Ni-NTA
matrix. After 1 hour and after 2 hours 40 µl of the cleared lysate was taken (flowthrough)
After the binding of the 6xHis-tagged protein on the Ni-NTA matrix, the cleared lysate
was washed three times with washing buffer (1 minute, 2000 rpm, 4 ºC). For reducing
the unspecific binding of other His-containing proteins on the Ni-NTA agarose beads
one washing step with 50 mM imidazole was performed. The 6xHis-tagged protein was
then eluted in 1 ml elution buffer. One control sample was taken before elution from the
Ni-NTA agarose beads to further test the protein binding to the matrix (tb). A second
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control sample was taken after elution to check that the protein was completely eluted
from the matrix (tb after elution). As a final control a sample of 30 µl was taken from
the eluted fraction. All samples were boiled in 1x- or 5x SDS sample buffer at 95 ºC for
6 minutes and analyzed by SDS-PAGE.
3.2.6 Glutathione based purification of GST-tagged recombinant proteins
Glutathione-S-transferase (GST) binds to glutathione with high affinity and specificity. GST-
tagged proteins can then be purified by using immobilized glutathione (glutathione sepharose).
The purification was performed under non-denaturing conditions, because GST loses its ability
to bind glutathione under denaturing conditions. For the bacterial expression of the protein
of interest, the pGEX-4T-3 vector was used.
Procedure for a 500 ml bacterial culture:
 Culture growth:
50 ml of LB Medium containing 10 % ampicillin (1:1000) and chloramphenicol (34
mg/ml) (1:1000) were inoculated over night at 37 ºC with continuous shaking. At
the next day 500 ml of LB medium supplemented with 10 % ampicillin (1:1000) and
chloramphenicol (34 mg/ml) (1:1000) were inoculated with the noninduced overnight
culture (1:10). The culture grew at 37 ºC with shaking (160 rpm) until an OD600 of
0,5 was reached. The temperature was lowered to 21 ºC and after an OD600 of 0,6 was
reached the expression was induced by adding IPTG to a final concentration of 0,1 mM.
The culture was incubated overnight at 21 ºC. One 500 µl sample was taken immediatly
before the induction (noninduced control t0), whereas another 500 µl sample was taken
after the induction at the second day (induced control tI). The cells were harvested
by centrifugation (Beckman Coulter; Avanti J26XP -> JA14 rotor) at 13000 rpm, 30
minutes, 4 ºC and pellets were frozen at -20 ºC.
 Protein extraction:
The cell pellet was thawed on ice and resuspended in TBST at 2-5 ml per gram wet
weight. The cell lysate was sonificated 16x 10 seconds 80-100 % and centrifuged (Beck-
man Coulter; Avanti J26XP -> JA25.50 rotor) at 15000 rpm at 4 ºC for 30 minutes.
The cleared lysate was saved and a sample of 40 µl was taken (soluble protein fraction).
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The pellet was resuspended in 5-10 ml TBST and 20 µl were taken for the insoluble
protein control (pellet). Proteins were purified by using a batch purification method un-
der non-denaturing conditions. Glutathion sepharose 4b beadsolution was washed three
times with TBST and added to the supernatant. The supernatant and the glutathion
sepharose beads were then rotated for 2 hours at 4 ºC on a rotator. After the binding of
the GST-tagged protein on the glutathion sepharose matrix the supernatant was washed
three times with TBST (1 minute, 2000 rpm, 4 ºC). All samples were boiled in 1x- or
5x SDS sample buffer at 95 ºC for 6 minutes and analyzed by SDS-PAGE.
 Elution of the GST protein and the GST-tagged protein (for protein-lipid overlay assays)
The GST protein respectively the GST-tagged protein bound to the GST-sepharose were
incubated two times in 200 µl GST elution buffer at 4 ºC on a rotator. The protein eluat
was dialyzed over night in 1,5 l TBST at 4 ºC by using Slide-A-Lyzer Dialysis cassettes
(10000 MWCO) (ThermoScientific).
3.2.7 Protein-lipid overlay assay
By using a protein-lipid overlay assay potential protein-phospholipid interactions can be iden-
tified. Different phospholipid species are spotted on a membrane. That so-called PIP strip
can than be incubated with purified GST- or 6xHis-tagged proteins. Phospholipid bound pro-
teins can be detected with an antibody against the GST or the 6xHis tag and a secondary
HRP-conjugated antibody. Finally, the HRP-linked antibody was detected by using an ECL
reagent kit (enhanced chemiluminescence Amersham). The light signal was detected by au-
toradiography using a x-ray film.
Protein-lipid overlay assays were performed by using PIP strips from Invitrogen.
3.2.7.1 Experimental procedure
1. Block the membrane. The membrane was incubated for one hour at room temperature
in TBST + 3% BSA with gently agitation.
2. Incubate the membrane. The membrane was incubated for 4 hours at room temperature
with the protein of interest in TBST/3 % BSA.
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3. Wash the membrane. The membrane was washed with TBST/3 % BSA three times
using gently agitation at room temperature for 10 minutes each time.
4. Detect the protein. The membrane was blocked in TBST/5 % milk powder over night at
4 ºC. GST and GST-tagged proteins were detected by using an anti-GST antibody and
a secondary HRP-conjugated anti goat antibody. 6xHis-tagged proteins were detected
by using a penta-His antibody and a secondary HRP-conjugated anti mouse antibody.
3.3 Protein-Protein Interaction studies
3.3.1 Co-immunoprecipitation
Immunoprecipitation (IP) is used to isolate and concentrate a specific protein from a solution
by using an antibody that specifically binds to that protein. The antibody is coupled to a
solid substrate during the process of binding to the target protein. Immunoprecipitation of
intact protein complexes is known as co-immunoprecipitation (Co-IP). Co-IP works by using
an antibody that targets a known protein that is believed to be a member of a larger complex of
proteins. By targeting this known member with an antibody it may become possible to pull the
entire protein complex out of solution and thereby identify unknown members of the complex.
Co-immunoprecipitations can be performed to determine if protein-protein interactions are
occurring in vivo. Consequently, any cellular protein that interacts with the target protein
will also be pulled out.
Throughout the course of this work N-terminally Myc-epitope tagged proteins were used.
The Myc-epitope tagged protein acts as the "bait" to capture a putative binding partner
(i.e., the "prey"). The putative binding partner was an eGFP- or mStrawberry-tagged fusion
protein. To immunoprecipitate the bait from the cell lysate, an anti-Myc 9E10 antibody
was used. The Myc-epitope tagged bait protein bound to the anti-Myc 9E10 antibody was
then immobilized by binding to Protein-G-Agarose. Protein G binds the Fc-parts of most
mammalian IgGs with high affinity.
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Procedure
HEK 293 cells were seeded in four, with 10 % Poly-L-lysine solution coated, wells of a 6-
well-plate. Cells were cotransfected with the Myc-epitope tagged protein and the eGFP-
or mStrawberry-tagged protein. Cells were lysed after 48 hours in co-immunoprecipitation
buffer (1 ml per 3 wells) with or without EDTA at 4 ºC under rotation for 40 minutes. One
well was lysed in 100 ml 1x SDS sample buffer and used as a control sample (total). The
co-immunoprecipitation buffer was supplemented with Protease Inhibitors (complete, Mini,
EDTA-free Protease Inhibitor Cocktail tablets; Roche). One tablet was used per 10 ml co-
immunoprecipitation buffer. After centrifugation of the cell lysate (10 minutes, 4 ºC, 14000
rpm) samples were taken from the supernatant and the pellet fraction. The Myc-epitope
tagged protein was pulled with an anti-Myc 9E10 antibody (4 µg/ml). The anti-Myc 9E10
antibody was added and the cleared cell lysates were incubated at 4 ºC for 1 hour. 50 ml
Proteine-G-Agarose, earlier washed 3x with co-immunoprecipitation buffer, was added to the
cell lysates and incubated at 4 ºC for 2 hours under rotation. After 3 washing steps with
co-immunoprecipitation buffer Proteine-G-Agarose beads were boiled in 30 ml 1x SDS sample
buffer. Additionally, two controls were performed. First, HEK 293 cells were transfected
with the Myc-epitope tagged protein and an empty pEGFP- or mStrawberry vector, to ensure
that the binding doesn't depend on the eGFP- or mStrawberry-tag. Second, HEK 293 cells
were only transfected with the eGFP- or mStrawberry-tagged protein, to show that the protein
doesn't stick to the Protein-G-Agarose beads. All samples were boiled in 1x- or 5x SDS-sample
buffer for 6 minutes at 95 ºC and analyzed by SDS-PAGE.
3.3.2 Pull down assay with purified 6xHis-tagged and GST-tagged
recombinant proteins
A pull down assay is a technique used to analyze protein-protein interaction. Throughout the
course of this work a GST-pull down assay was performed. The bait protein was fused to
a GST-tag, whereas the prey, the putative binding partner, was fused to a 6xHis-tag. Both
proteins were expressed in E. coli / Rosettas and purified. The GST-tagged protein bound
to GST-beads were therefore incubated with the eluted 6xHis-tagged protein. As a control,
GST bound to GST-beads were also incubated with the 6xHis-tagged protein to exclude that
binding depends on the GST tag.
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Procedure
The purified and eluted 6xHis-tagged protein was dialyzed over night in 1,5 l of pull down
buffer at 4 ºC by using a Slide-A-Lyzer Dialysis cassette (10000 MWCO) (ThermoScientific).
To avoid unspecific binding to the GST-beads the eluted fraction of the 6xHis-tagged protein
was preincubated with 100 µl GST-beads per 1 ml eluat for 30 minutes at 4 ºC on a rotator.
After that preincubation step the GST-beads/eluat was centrifuged at 4 ºC for 5 minutes
(14000 rpm). The supernatant was then used for the incubation with the GST-tagged protein
bound to GST-beads or the GST protein as a control. Proteins were incubated for 1 hour
on a rotator at 4 ºC. After the binding step GST-beads were washed 5 times with pull down
buffer (5 minute rotation at 4 ºC; 5 minute centrifugation at 4 ºC at 500 g). GST-beads were
boiled in 30 µl 1x SDS sample buffer for 6 minutes at 95 ºC. All samples were analyzed by
SDS-PAGE.
3.4 Cell Biological Methods
3.4.1 Cell culture
HeLa, HEK 293 and MDCK cells were cultured in Dulbecco's modified Eagle's medium
(DMEM, Invitrogen) supplemented with 10 % fetal calf serum (FCS; HyClone), 2 mM L-
glutamate (Glu), and 100 units/ml penicillin and 100 µg/ml streptomycin at 37 ºC and 10%
CO2.
3.4.2 Coating of 6-well plates with Poly-L-lysine
Poly-L-lysine coated 6-well plates provide higher adhesion, resulting in the reduced loss of cells
during processing. Wells were incubated in 10 % Poly-L-lysine solution in H2O dest. for 5
minutes at room temperature. Afterwards, the 10 % Poly-L-lysine solution was removed and
wells were leave to dry. Finally, the 6-well plates were washed 3 times with PBS.
3.4.3 Establishing a stable cell line
Throughout the course of this work a stable constitutively expressing MDCK-Myc-Spir-2 cell
line has been used. To deliver the exogenous Myc-epitope tagged Spir-2 into MDCK cells,
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the pBABE-puro vector was used. This vector provides retrovirus sequences for the stable
insertion and expression of exogenous genes. This cell line was already available and was used
for further analysis.
3.4.4 Transfection
Cells were transfected with Lipofectamine according to the manufacturer's recommendations.
Cells were seeded approximately 20 hours before transfection in DMEM full medium (10 %
FCS, Pen/Strep, L-Glu). At the day of transfection the cells reached a confluency of 80-90
%. 6 µl of Lipofectamine were incubated with 1,4 - 2,0 µg of DNA in DMEM without FCS,
Pen/Strep, L-Glu for 20 minutes and added to the cells. After 5-6 hours the medium was
changed to DMEM containing FCS, Pen/Strep and L-Glu. Cells were allowed to express
proteins for 20 - 48 hours.
3.4.5 Immunocytochemistry
HeLa cells were seeded on glass coverslips (15 mm diameter) in 6-well plates. The cells were
transfected with the indicated plasmid vectors by a liposome transfection method (Lipofec-
tamine, Invitrogen) at the next day. 24-36 hours after transfection the cells were fixed with 3,7
% paraformaldehyde in PBS (20 minutes, 4 ºC) and permeabilized with 0,2 % Triton X-100 in
PBS (3 1/2 minutes, room temperature). For immunodetection, the fixed cells were incubated
for 1 hour in the presence of the indicated primary antibody, followed by three washing steps
with PBS. After the incubation with the indicated secondary antibody for 1 hour, cells were
washed 3 times with PBS and were mounted in a Mowiol solution.
The cells were analyzed with a Leica AF600LX imaging system equipped with a Leica
HCX PL APO63X/1.30 glycerol objective and a Leica DFC350FX camera. For colocalization
studies, images were deconvoluted (blind) with the deconvolution software from Leica (Le-
ica Application Suite Advanced Flourescense) and further processed with ImageJ or Adobe
Photoshop to optimize the contrast and brightness.
3.4.5.1 Detection of endogenous F-actin using Phalloidin
The phallotoxin phalloidin from death cap (Amanita phalloides) binds to F-actin and prevents
its depolymerization leading to a decreased dissociation of actin monomers from F-actin.
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Furthermore it inhibits ATP hydrolysis activity (Cooper, 1987, Barden et al., 1987). The
specific binding to F-actin can be used to stain endogenous F-actin in immunocytochemical
experiments. In this study endogenous F-actin in HeLa cells was detected with rhodamine-
conjugated phalloidin (Molecular Probes) at a 1:20 dilution. Fixed cells were incubated for
1 hour in the presence of the indicated primary antibody and rhodamine-phalloidin, followed
by three washing steps with PBS. After the incubation with the indicated secondary antibody
for 1 hour, cells were washed 3 times with PBS and were mounted in mowiol solution.
3.4.6 Live cell imaging
HeLa cells were seeded on Willco glass bottom dishes. The cells were transfected at the next
day and assayed 24-36 hours after transfection. The cells were analyzed with a Leica AF600LX
imaging system (see 3.4.5 Immunocytochemistry).
3.4.6.1 Comparison of vesicle length and motility
Comparison of vesicle length
To measure and compare the length of different Spir-2 versions, HeLa cells were transiently
transfected with eGFP-Spir-2, eGFP-Spir-2-DKW and eGFP-Spir-2-DKIND (Fig. 4.3) and
used for live cell imaging experiments. 5 cells were imaged, and a total of 100 vesicles were
measured of each Spir-2 protein version. Length of the vesicles was determined with the
software from Leica (Leica Application Suite Advanced Flourescense).
To analyze the impact of Spir-2 and Spir-2-DKW on Rab11a-associated vesicles, HeLa
cells were transfected with mStrawberry-Rab11a, mStrawberry-Rab11a + eGFP-Spir-2 and
mStrawberry-Rab11a + eGFP-Spir-2-DKW. 3 cells were measured and a total of 100 vesicles
were measured of each transfection.
Analogous to the effect of Spir-2 on Rab11a vesicles, Spir-2 has also an effect on myosin
Vb- associated vesicles. To analyze the alteration of MyoVb-cc-tail-positive structures, HeLa
cells were transfected with mStrawberry-MyoVb-cc-tail, mStrawberry-MyoVb-cc-tail + eGFP-
Spir-2 and mStrawberry-MyoVb-cc-tail + eGFP-Spir-2-DKW. 4-5 cells were compared and a
total of 100 vesicles were measured of each transfection.
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Comparison of vesicle motility
To analyze the vesicle motility of eGFP-Spir-2, eGFP-Spir-2-DKW and eGFP-Spir-2-DKIND
associated vesicles, time-lapse movies were made, by taking a picture every 2 seconds for
one minute (31 pictures in total). To calculate the motility rate, 5 cells of each transfection
were segmented in squares of 2,5 µm2 size and the retention time of 20 vesicles per cell was
measured.
3.4.6.2 Treatment of living HeLa cells with nocodazole
Nocodazole disrupts microtubules by promoting their depolymerization. To analyze the ef-
fect of microtubule depolymerization by nocodazole, transfected living HeLa cells were filmed
for 1 minute before treatment with nocodazole. Cells were treated with 20 mM nocoda-
zole in DMEM full medium with 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES). Another time-lapse movie was made after 30 minutes from the same cells. All
movies were made by taking a picture every 2 seconds for one minute.
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4 RESULTS
4.1 Aim of the work
Spir proteins are targeted towards intracellular membranes by a C-terminal modified FYVE
zinc finger motif. Although a role for Spir-1 in vesicle transport processes of the exocytic
pathway (Kerkhoff et al., 2001) and the transport beyond early endosomes (Morel et al.,
2009) has been described, the function and regulation of the actin organizers at vesicular
membranes is unknown. In the course of this work the role of the actin nucleation factor Spir-
2 in intracellular vesicle transport processes was analyzed. The objective was to examine the
recruitment of Spir-2 to specific membranes, to identify factors, which are important for Spir-2
targeting and to study the effect of Spir-2 deletion mutants on specific intracellular membrane
compartments. The C-terminal part of Spir-2, consisting of the Spir-box and the modified
FYVE zinc finger was analyzed with particular interest, assuming that this part of the protein
is crucial for the membrane targeting and therefore for the function of Spir proteins in vesicle
transport processes. Furthermore, the influence of the actin and the microtubule cytoskeleton
on Spir-2 mediated vesicle transport processes should be elucidated.
4.2 Cellular localization of Spir-2
4.2.1 Spir-2 is located at tubular vesicular structures
To analyze the cellular localization of Spir-2 in HeLa cells, N-terminally eGFP-, and Myc-
epitope tagged proteins were used. EGFP-Spir-2 and two truncated versions of Spir-2, Spir-2-
DKW, in which the KIND domain and the 4 WH2 domains are deleted, and Spir-2-DKIND,
were used for live cell imaging and immunofluorescence experiments (Fig. 4.1). To exclude,
that the N-terminal tag alters the localization of Spir-2, eGFP-Spir-2-DKW and Myc-Spir-
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2-DKW constructs were coexpressed in HeLa cells. Cells were fixed and the Myc-epitope
tagged Spir-2-DKW protein was detected by using the anti-Myc 9E10 mouse monoclonal an-
tibody (1,3 µg/ml, Santa Cruz) and a rhodamine isothiocyanate (TRITC)-conjugated donkey
anti-mouse IgG secondary antibody (5 µg/ml) (Jackson ImmunoResearch Laboratories). An
identical localization pattern was observed, supporting the fact that both tags don't modify
the subcellular localization (Fig. 4.2).
Figure 4.1: Domain structure of the Spir-2 protein and two deletion constructs
Figure 4.2: Localization of Spir-2-DKW proteins
HeLa cells were cotransfected with Myc-Spir-2-DKW and eGFP-Spir-2-DKW. The cellular
localization of the Myc-Spir-2-DKW protein was determined by immunostain experiments
(red fluorescence). The localization of eGFP-Spir-2-DKW was detected by GFP fluorescence
(green fluorescence). Images were deconvoluted (blind) with the deconvolution software from
Leica. They show an identical localization pattern, indicating that both tags don`t change the
subcellular localization.
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To analyze the length and motility of Spir-2, Spir-2-DKW and Spir-2-DKIND-associated
vesicles, live cell imaging experiments were performed. The different Spir-2 protein versions are
all located to elongated tubular structures (Fig. 4.3). The comparison of the vesicle length,
revealed that Spir-2 and Spir-2-DKIND-associated vesicles are very similar regarding their
length. By comparison, Spir-2-DKW-associated vesicles show a more elongated morphology
(Fig. 4.3 C). Although, the average elongation differs only slightly, the maximum length is
increased up to 9 µm.
Furthermore, the motility of those three Spir-2 versions was compared in live cell imaging
experiments. HeLa cells were transiently transfected with Spir-2, Spir-2-DKIND and Spir-2-
DKW and one minute time-lapse movies were made, by taking a picture every 2 seconds. 100
vesicles of 5 cells per Spir-2 version were analyzed, regarding their vesicle retention time. Spir-
2-DKIND-associated vesicles displayed a static behavior. In most cases, the vesicles exhibit
the maximal retention time of 60 seconds. In contrast, Spir-2-DKW and Spir-2-associated
vesicles are motile (Fig. 4.3 B,D). Spir-2-DKW exhibits the highest rate of motility.
Spir-2-DKW contains the Spir-box and the modified FYVE zinc finger motif, which is crucial
for the membrane targeting of Spir proteins. Therefore, most experiments were performed with
Spir-2-DKW to analyze the function of the C-terminus of Spir-2 in vesicle transport processes
under the assumption that the C-terminal part without the 4 WH2-domains and the KIND
domain is sufficient for the correct membrane targeting.
50
Figure 4.3: Spir-2 proteins are found on tubular vesicular structures
Comparison of Spir-2 and two Spir-2 deletion mutants A Live cell imaging of HeLa cells
transfected with expression vectors directing the expression of eGFP-Spir-2, eGFP-Spir-2-
DKIND and eGFP-Spir-2-DKW. B Time-lapse movies of living HeLa cells were made by
taking a picture every 2 seconds. Note that for eGFP-Spir-2 and eGFP-Spir-2-DKW the time
interval between the shown pictures is 2 seconds, whereas for eGFP-Spir-2-DKIND the time
interval is 4 seconds. C Comparison of the length of eGFP-Spir-2, eGFP-Spir-2-DKIND and
eGFP-Spir-2-DKW-associated vesicles. 5 cells were imaged and a total of 100 vesicles was
measured for each Spir-2 version. D Comparison of the motility of eGFP-Spir-2, eGFP-Spir-
2-DKIND and eGFP-Spir-2-DKW-associated vesicles. 5 cells were imaged and a total of 100
vesicles was measured for each Spir-2 version. Cells were segmented in squares of 2,5 µm2 and
the retention time of 20 vesicles per cell was measured.
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4.2.2 Spir-2 shows partial colocalization to Rab11a but not to Rab6a
To determine the exact subcellular localization of Spir-2, HeLa cells were cotransfected with
mStrawberry-tagged Rab11a together with eGFP-tagged Spir-2 and Spir-2-DKW. Several
tubular structures could be detected which contain both proteins (Fig. 4.4 A). Rab proteins are
used as markers for specific membrane compartments and it is well known, that they function
as regulators of vesicle transport processes. The fact that Spir-2 and Rab11a are present
at the same motile structures support the role for Spir-2 in regulation of vesicle trafficking
processes. To characterize the identity of Spir-2-positive tubular vesicles in more detail the
small G protein Rab6a was used to show if Spir-2 is localized at Rab6a-positive compartments.
Rab6a is localized at medial - and trans-Golgi membranes and mediates intra-Golgi transport
processes, like retrograde Golgi to endoplasmic reticulum traffic (Nery et al., 2006), but also
post Golgi transport of secretory vesicles to the plasma membrane (Grigoriev et al., 2007).
By performing live cell imaging experiments with eGFP-Spir-2-DKW/mStrawberry-Rab6a
transfected Hela cells it was shown that Spir-2 doesn't show colocalization to Rab6a-positive
membrane structures (Fig. 4.5). This suggests, that Spir-2 regulates vesicle traffic along the
Rab11 but not along the Rab6-pathway.
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Figure 4.4: Partial colocalization of Spir-2 and Rab11a
Spir-2-DKW alters the morphology of Rab11a-positive vesiclesA HeLa cells were cotransfected
with eGFP-Spir-2-DKW and mStrawberry-Rab11a. The localization of both proteins were
analyzed in living HeLa cells, where they show colocalization on elongated tubular vesicles. B
HeLa cells were transfected with strawberry-Rab11a. Rab11a is located at dotlike vesicles in
contrast to the elongated tubular structures in eGFP-Spir-2-DKW and mStrawberry-Rab11a
transfected HeLa cells. C Comparison of the length of eGFP-Spir-2-DKW/mStrawberry-
Rab11a-associated vesicles in A, with eGFP-Spir-2/mStrawberry-Rab11a-associated vesicles
and mStrawberry-Rab11a-positive vesicles in B. 3 cells were imaged in all experiments and a
total of 100 vesicles are measured for each transfection.
53
Figure 4.5: Spir-2 shows no colocalization to Rab6a-positive compartments
HeLa cells were cotransfected with eGFP-Spir-2-DKW and mStrawberry-Rab6a. Living HeLa
cells were imaged and the localization of both proteins was compared. Rab6a shows a dif-
ferent localization pattern as Spir-2-DKW. Rab6a-positive vesicles show no elongation, like
Rab11a-associated vesicles, suggesting that Spir-2-DKW has no effect on Rab6a-positive com-
partments.
Rab11a is implicated in transport processes along the recycling pathway, but it is also
localized to the TGN, involved in post Golgi secretory traffic. Furthermore, a role for Rab11a
in retrograde traffic between recycling endosome and the TGN has also been shown, where it
plays a role in exit of membranes from recycling endosomes (Wilcke et al., 2000). Although,
Spir-2 colocalizes partially with Rab11a on intracellular membranes an interaction between
Spir-2-DKW and Rab11a, Rab25 or Rab11-FIP2 couldn't be shown (Fig. 4.6; Fig. 4.7).
Therefore, other proteins, like the GTP-binding proteins of the Arf family were analyzed with
respect to their function in Spir-2 membrane recruitment.
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Figure 4.6: Neither Rab11a nor Rab25 interact with Spir-2-DKW
Co-IP of Myc-Spir-2-DKW and mStrawberry-Rab25/mStrawberry-Rab11a. Myc-Spir-2-
DKW was pulled from a HEK 293 cell lysate using the anti-Myc 9E10 antibody (4 µg/ml).
mStrawberry-Rab25 or mStrawberry-Rab11a couldn`t be immunoprecipitated. The mStraw-
berry protein was used as a negative control. SDS-PAGE: 10% Polyacrylamide gel; Immun-
odetection: a-living colors dsRed (1:1000); a-rabbit-HRP (1:5000); a-Myc 9E10 (1:200); a-
mouse-HRP (1:4000); Abbreviations: kDa kilo Dalton; IP immunoprecipitation; t total; s
supernatant (soluble protein fraction; supernatant fraction after centrifugation at 14000 rpm);
p pellet (insoluble protein fraction; pellet fraction after centrifugation at 14000 rpm)
This figure is representative of two separate experiments.
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Figure 4.7: Rab11-FIP2 doesn't interact with Spir-2-DKW
Co-IP of Myc-Spir-2-DKW and eGFP-Rab11-FIP2. Myc-Spir-2-DKW was pulled from a
HEK 293 cell lysate using the anti-Myc 9E10 antibody (4 µg/ml). eGFP-Rab11-FIP2 was not
immunoprecipitated. The eGFP protein was used as a negative control. eGFP-Rab11-FIP2
was not immunoprecipitated from HEK 293 lysates when Myc-Spir-2-DKW was absent. SDS-
PAGE: 7,5% Polyacrylamide gel; Immunodetection: a-living colors GFP (1:100); a-rabbit-HRP
(1:5000); a-Myc 9E10 (1:200); a-mouse-HRP (1:4000); Abbreviations: kDa kilo Dalton; IP
immunoprecipitation; t total; s supernatant (soluble protein fraction, supernatant fraction
after centrifugation at 14000 rpm); p pellet (insoluble protein fraction; pellet fraction after
centrifugation at 14000 rpm)
This figure is representative of two separate experiments.
4.2.3 Spir-2 colocalizes to the small G protein Arf1
Arf1 regulates many transport processes at the Golgi apparatus. It controls intra-Golgi traffic
and also TGN to plasma membrane transport via endosomal structures. Arf1 is implicated
in vesicle formation by recruiting coat proteins, regulating the phospholipid environment and
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modulating actin structures (Bonifacino and Lippincott-Schwartz, 2003, Godi et al., 1999,
Myers and Casanova, 2008).
To elucidate if Spir-2-associated vesicles are somehow regulated by Arf1, HeLa cells were
cotransfected with Myc-epitope tagged Spir-2-DKW and Arf1-eGFP, and the subcellular lo-
calization of both proteins was determined by immunofluorescence staining experiments. The
Myc-epitope tagged Spir-2-DKW protein was detected with an anti-Myc9E10 antibody and a
TRITC-conjugated anti-mouse IgG secondary antibody. Arf1 and Spir-2-DKW are colocalized
on vesicular structures (Fig. 4.8). To further confirm the connection between Spir-2 and Arf1
a co-immunoprecipitation experiment was performed. It could be shown that Spir-2-DKW
and Arf1 co-immunoprecipitates in a complex (Fig. 4.9), supporting an interaction between
both proteins. Therefore, a Spir-2/Arf1 complex mediates transport of tubular vesicles.
Figure 4.8: Spir-2 is localized at Arf1-positive compartments
HeLa cells were cotransfected with Myc-Spir-2-DKW and Arf1-eGFP. Images were deconvo-
luted (blind) with the deconvolution software from Leica. Arf1 and Spir-2-DKW colocalize on
tubular vesicles
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Figure 4.9: Arf1 is in a complex with Spir-2-DKW
Co-IP of Myc-Spir-2-DKW and Arf1-eGFP. Myc-Spir-2-DKW was pulled from a HEK 293
cell lysate using the anti-Myc 9E10 antibody (4 µg/ml). Arf1-eGFP but not eGFP was
immunoprecipitated with Spir-2-DKW. Arf1-eGFP was not immunoprecipitated from HEK
293 lysates when Myc-Spir-2-DKW was absent.
SDS-PAGE: 10% Polyacrylamide gel; Immunodetection: a-living colors GFP (1:100); a-rabbit-
HRP (1:5000); a-Myc9E10 (1:200); a-mouse-HRP (1:4000); Abbreviations: kDa kilo Dalton;
IP immunoprecipitation; t total; s supernatant (soluble protein fraction; supernatant fraction
after centrifugation at 14000 rpm); p pellet (insoluble protein fraction; pellet fraction after
centrifugation at 14000 rpm)
This figure is representative of three separate experiments.
58
4.2.4 Spir-2-DKW vesicles are localized to microtubules
A major question to be answered was, in which way the cytoskeleton regulates Spir-2 mediated
membrane transport. First, the role of the microtubule cytoskeleton in Spir-2-mediated vesicle
traffic was examined. HeLa cells were therefore coexpressed with eGFP-Spir-2-DKW, fixed
and endogenous a-tubulin was detected with an anti-a-tubulin mouse monoclonal antibody
(1 µg/ml) to stain the microtubule cytoskeleton. Spir-2-DKW partially colocalized with en-
dogenous a-tubulin, suggesting that the transport of Spir-2-associated vesicles could depend
on microtubule filaments (Fig. 4.10).
To test this dependency between Spir-2-driven vesicle transport and the microtubule cy-
toskeleton, eGFP-Spir-2-DKW transfected HeLa cells were treated with the microtubule de-
polymerizing drug nocodazole. 1 minute movies from cells were taken before and after treat-
ment with nocodazole to analyze the alteration of vesicle motility and morphology. Depoly-
merization of microtubule filaments by nocodazole (20 mM) completely disrupts Spir-2-DKW-
positive structures with respect to their length and also their motility (30 minutes after treat-
ment). Almost all Spir-2-DKW vesicles showed a decreased elongation (Fig. 4.11). Further-
more, also the motility of Spir-2-DKW was severely limited. This suggests, that the elongation
of Spir-2 vesicles depends on an intact microtubule cytoskeleton, supposing a model in which
Spir-2-mediated vesicle transport requires microtubules.
Figure 4.10: Spir-2 vesicles are localized to microtubules
HeLa cells were transiently transfected with pEGFP-C1-Spir-2-DKW. The subcellular localiza-
tion of endogenous a-tubulin was determined by immunostain experiments (red fluorescence)
and the localization of eGFP-Spir-2-DKW was detected by GFP fluorescence (green fluores-
cence). Localization of Spir-2-DKW on microtubules is indicated (white arrows).
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Figure 4.11: Spir-2 vesicle elongation depends on microtubules
Live cell imaging of HeLa cells transiently transfected with pEGFP-C1-Spir-2-DKW A Before
treatment with the microtubule depolymerizing drug nocodazole, long and motile tubular
structures are present. B After treatment with nocodazole (30 minutes) tubular structures
are collapsed and exhibit decreased motilityC. Decreased motility of Spir-2 vesicles is indicated
by white arrows C.
4.2.5 Tubular Spir-2-DKW vesicles are coated with F-actin
Considering the fact that Spir is an actin nucleation factor and therefore regulates the actin
cytoskeleton directly it was important to analyze the influence of the actin cytoskeleton of
Spir-2- mediated vesicle transport. To show the association of endogenous F-actin and Spir-2
in HeLa cells, cells were transfected with Myc-Spir-2-DKW. After fixation and permeabi-
lization, endogenous F-actin was detected with rhodamine-phalloidin, whereas transfected
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exogenous Myc-Spir-2-DKW was detected with an anti-Myc 9E10 antibody and a fluorescin-
isothiocyanate (FITC)-conjugated donkey anti-mouse secondary antibody. Spir-2-DKW was
found to be localized on F-actin-positive vesicles, suggesting that in addition to the micro-
tubule cytoskeleton also actin filaments are required for Spir-2-dependent vesicle transport
(Fig. 4.12).
Figure 4.12: Spir-2-DKW vesicles are F-actin coated
HeLa cells were transfected with Myc-Spir-2-DKW, fixed and F-actin was detected with
Rhodamine-Phalloidin (red fluorescence), whereas the Myc-Spir-2-DKW protein was detected
with an anti-Myc 9E10 antibody and a secondary FITC-conjugated antibody (green fluo-
rescence). Images were deconvoluted (blind) with the deconvolution software from Leica.
Spir-2-DKW is localized to F-actin-positive tubular vesicles (white arrows).
4.2.6 Spir-2-DKW colocalizes and is in complex with the tail domain of
myosin Vb
An interesting observation was that Spir-2-DKW, which lacks the KIND domain and the four
WH2 domains and therefore the ability to nucleate actin filaments, also shows colocalization
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to actin (Fig. 4.12). This suggests that the actin nucleation function of Spir is not crucial for
the association of Spir-2-positive vesicles with the actin cytoskeleton.
It has been shown, that myosin Vb and Rab11a are involved in several transport processes
(Volpicelli et al., 2002, Fan et al., 2004, Hales et al., 2002, Swiatecka-Urban et al., 2007).
Localization of myosin Vb and Rab11 in HeLa and MDCK cells shows a very similar cellular
distribution of both proteins (Lapierre et al., 2001). Throughout the course of this work a
C-terminal fragment of the actin motor protein myosin Vb was used, which contain the cargo
binding globular tail domain and the adjacent coiled coil domains (Fig. 4.13 A). Coexpression
of mStrawberry-tagged MyoVb-cc-tail and eGFP-Rab11a in HeLa cells shows a very similar
localization pattern of both proteins (Fig. 4.13 B).
Figure 4.13: Colocalization of the tail domain of myosin Vb and Rab11a in
HeLa cells
A Domain structure of the actin-dependent motor protein myosin Vb. Tail domain fragments
of myosin Vb (MyoVb-cc-tail) are used as dominant negative mutants specifically for myosin
Vb-dependent vesicle transport.
B Live cell imaging of HeLa cells transfected with expression vectors directing the expression of
eGFP-Rab11a and mStrawberry-MyoVb-cc-tail. They show an identical localization pattern.
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To elucidate the potential relation between Spir-2 and myosin Vb, HeLa cells were cotrans-
fected with eGFP-Spir-2-DKW and mStrawberry-MyoVb-cc-tail. The tail domain of myosin
Vb is often used as a dominant negative mutant for myosin Vb-dependent vesicle transport
processes. This mutant has the ability to bind myosin Vb-specific cargo but does not actively
transport it. Spir-2-DKW and MyoVb-cc-tail both localized to the same elongated tubular
structures (Fig. 4.14).
To confirm the connection of Spir-2 and myosin Vb, interaction studies were performed.
Myc-Spir-2-DKW and mStrawberry-MyoVb-cc-tail were cotransfected in HEK 293 cells. That
study showed that MyoVb-cc-tail was immunoprecipitated with Spir-2-DKW, supporting an
interaction between Spir-2 and myosin Vb (Fig. 4.15).
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Figure 4.14: Spir-2 shows colocalization to the tail domain of myosin Vb
Spir-2-DKW alters the morphology of MyoVb-cc-tail-positive vesicles A HeLa cells were co-
transfected with eGFP-Spir-2-DKW and mStrawberry-MyoVb-cc-tail. The localization of
both proteins were analyzed in living HeLa cells, were they show colocalization at tubular
elongated vesicles. B HeLa cells were transfected with mStrawberry-MyoVb-cc-tail. MyoVb-
cc-tail is located at dotlike vesicles in contrast to the elongated tubular structures in eGFP-
Spir-2-DKW and mStrawberry-MyoVb-cc-tail transfected HeLa cells. C Comparison of the
length of vesicles. 3 cells were imaged and a total of 100 vesicles are measured for each
transfection.
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Figure 4.15: MyoVb-cc-tail is in a complex with Spir-2-DKW
Co-IP of Myc-Spir-2-DKW and mStrawberry-MyoVb-cc-tail. Myc-Spir-2-DKW was pulled
from a HEK 293 cell lysate using an anti-Myc 9E10 antibody (4 µg/ml). mStrawberry-MyoVb-
cc-tail but not mStrawberry was immunoprecipitated with Myc-Spir-2-DKW. SDS-PAGE:
7,5 % Polyacrylamide gel; Immunodetection: a-living colors dsRed (1:1000); a-rabbit-HRP
(1:5000); a-Myc 9E10 (1:200); a-mouse-HRP (1:4000); Abbreviations: kDa kilo Dalton; IP
immunoprecipitation; t total; s supernatant (soluble protein fraction; supernatant fraction
after centrifugation at 14000 rpm); p pellet (insoluble protein fraction; pellet fraction after
centrifugation at 14000 rpm)
This figure is representative of three separate experiments.
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4.3 Function of Spir-2 in vesicle trafficking
4.3.1 Spir-2 and Spir-2-DKW alter the morphology of Rab11a-associated
vesicles
Spir-2 shows specific localization to Rab11a-positive vesicles. To analyze if Spir-2 has an effect
on Rab11a vesicle morphology, HeLa cells were transfected with N-terminally mStrawberry-
tagged Rab11a alone and together with eGFP-Spir-2 or eGFP-Spir-2-DKW. To measure the
vesicle length, 100 vesicles of 3 cells per transfection, were analyzed. Expression of Rab11a
results in Rab11a-associated vesicles with an average length of 1 µm (Fig. 4.4 B,C). In com-
parison, coexpression of Rab11a and Spir-2 or Spir-2-DKW leads to elongated Rab11a/Spir-
2 or Rab11a/Spir-2-DKW-positive vesicles, with an average length of 2-3 µm (Fig. 4.4).
Rab11a/Spir-2 and Rab11a/Spir-2-DKW-associated vesicles displayed a similar length to Spir-
2 or Spir-2-DKW vesicles (Fig. 4.4 A,C), suggesting that Spir-2 induced vesicle elongation
affects the morphology of Rab11a compartments. Rab11a/Spir-2-DKW-associated vesicles
showed a slightly increased elongation rate compared with Rab11a/Spir-2-positive vesicles,
very similar to the differences of Spir-2 and Spir-2-DKW-associated vesicles (Fig. 4.3 C). This
supports the assumption, that the alterations of the Rab11a compartment are specifically
induced by Spir-2 function.
4.3.2 Spir-2 and Spir-2-DKW alter the morphology of myosin Vb vesicles
The C-terminal tail domain of myosin Vb mediates cargo binding but lacks the motor domain.
MyoVb-cc-tail constructs could therefore be used as dominant negative mutants, which in-
hibit myosin Vb-dependent transport specifically. Myosin Vb and Spir-2 show colocalization
in HeLa cells (Fig. 4.14 A) and interact with each other via their C-termini (Fig. 4.15). To
measure the vesicle length, 100 vesicles of 4-5 cells per transfection were analyzed. As well as
Rab11a vesicles were altered by Spir-2, MyoVb-cc-tail-positive structures were also modified
by Spir-2 and Spir-2-DKW (Fig. 4.14). Besides, MyoVb-cc-tail/Spir-2-DKW-associated vesi-
cles exhibited an increased elongation rate up to 11 µm, suggesting that inhibition of Spir-2
dependent actin nucleation leads to the elongation of those vesicles. Furthermore, coexpression
of MyoVb-cc-tail and Spir-2-DKW results in highly elongated tubular vesicles whose motility
is inhibited (Fig. 4.16).
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Figure 4.16: MyoVb-cc-tail/Spir-2-DKW-positive vesicles exhibit decreased
motility
Live cell imaging of HeLa cells cotransfected with expression vectors directing the expression of
mStrawberry-MyoVb-cc-tail and eGFP-Spir-2-DKW. Time-lapse movies were made by taking
a picture every two seconds. Note that the time interval between the shown pictures is 4
seconds. MyoVb-cc-tail/Spir-2-DKW-positive vesicles are highly elongated (Fig. 4.14) and
exhibit decreased motility (white arrow).
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4.4 Spir-2 and Spir-1 C-termini form homo- and heteromers
and mediate binding to phospholipids
4.4.1 Purification of GST-Spir-2-DKW, 6xHis-Spir-2-DKW,
6xHis-Spir-1-DKW and 6xHis-SOS1-PH
To analyze the subcellular function of the Spir-box and the modified Spir FYVE domain Spir-
2-DKW and Spir-1-DKW proteins were expressed by using bacterial expression vectors and
finally purified. These purified proteins could then be used for protein-lipid overlay assays
and pull down experiments. The Ras GEF SOS1 (Son of sevenless) (NCBI ID: NM_005633)
activates Ras at the plasma membrane. The recruitment of SOS1 to the plasma membrane
via its pleckstrin homology (PH) domain requires phosphatidic acid generated by PLD2 (Zhao
et al., 2007). The PH domain of SOS1 is a phosphatidic acid binding domain. An N-terminally
6xHis-tagged PH domain was used as a positive control for the protein-lipid overlay assay.
Figure 4.17: Purification of 6xHis-Spir-2-DKW
Spir-2-DKW was N-terminally tagged with 6xHis residues. 6xHis tagged proteins could be
efficiently purified by using nickel-nitrilotriacetic acid (Ni-NTA) agarose. and purified by using
a Ni-NTA batch purification method under non-denaturing conditions (Qiagen).
Expression conditions: 0,1 mM IPTG, over night, 25 ºC; SDS-PAGE: 7,5 % Polyacrylamide
gel; Immunodetection: a-penta-His (1:1000); a-mouse-HRP (1:4000); Abbreviations: kDa kilo
Dalton; t0 non induced control; tI induced control; tb protein fraction bound to beads
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Figure 4.18: Purification of 6xHis-Spir-1-DKW
Spir-1-DKW was also N-terminally tagged with 6 His residues, comparable to the Spir-2-DKW
protein and was purified by using Ni-NTA agarose beads from Qiagen under non-denaturing
conditions.
Expression conditions: 0,1 mM IPTG, over night, 25 ºC; SDS-PAGE: 7,5 % Polyacrylamide
gel; Immunodetection: a-penta-His (1:1000); a-mouse-HRP (1:4000), Abbreviations: kDa kilo
Dalton; t0 non induced control; tI induced control
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Figure 4.19: Purification of GST-Spir-2-DKW (for pull down assays)
Additionally to the 6xHis-tagged Spir-2-DKW protein also a N-terminally GST-tagged Spir-
2-DKW protein was purified. The GST-tag leads to a much better solubility of the Spir-2
protein, which results in an increased yield of purified protein.
Expression conditions: 0,1 mM IPTG, over night, 21 ºC; SDS-PAGE: 7,5 % Polyacrylamide gel;
Immunodetection: a-GST (1:5000); a-goat-HRP (1:7000), Abbreviations: kDa kilo Dalton;
t0 non induced control; tI induced control, tb protein fraction bound to beads
Figure 4.20: Purification of GST-Spir-2-DKW and GST-control (for protein-
lipid overlay assays)
To analyze the phospholipid binding properties, the GST-tagged Spir-2-DKW protein was
eluted from the GST-beads. Expression conditions: 0,1 mM IPTG, over night, 21 ºC; SDS-
PAGE: 10 % Polyacrylamide gel; Immunodetection: a-GST (1:5000); a-goat-HRP (1:7000);
Abbreviations: kDa kilo Dalton; t0 non induced control; tI induced control
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Figure 4.21: Purification of 6xHis-SOS1-PH
The PH domain of SOS1 is a phosphatidic acid binding domain. An N-terminally 6xHis-tagged
PH domain was used as a positive control for the protein-lipid overlay assay.
Expression conditions: 0,1 mM IPTG, over night, 25 ºC; SDS-PAGE: 11 % Polyacrylamide
gel; Immunodetection: a-penta-His (1:1000); a-mouse-HRP (1:4000), Abbreviations: kDa kilo
Dalton; t0 non induced control; tI induced control, tb protein fraction bound to Ni-NTA beads
4.4.2 Interaction of the C-terminal part of Spir-2 and Spir-1
To further elucidate the mechanism in which Spir-membrane-targeting could be regulated,
interaction studies of C-terminal parts of Spir-1 and Spir-2 were performed. A well studied
FYVE domain containing protein is EEA1 (early endosome antigen 1). The localization of
EEA1 to early endosomal membranes depends on its C-terminus, which contains a Rab5 in-
teraction site and a FYVE domain. The FYVE domain selectively binds phosphatidylinositol
3-phosphat (PtdIns(3)P). Another important feature of EEA1 is its ability to dimerize (Du-
mas et al., 2001). The formation of EEA1 dimers is crucial for binding to early endosomal
membranes. Adjacent to the FYVE domain is a coiled coil domain, which is needed for the
dimerization. Considering that Spir proteins also consist of a FYVE domain it was obvious to
test the ability of Spir proteins to dimerize and to analyze the function of Spir dimerization
regarding membrane targeting and recruitment.
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First, a co-immunoprecipitation assay was performed. HEK 293 cells were transfected with
eGFP-Spir-2-DKW and Myc-Spir-2-DKW. The co-immunoprecipitation experiment revealed
that eGFP-Spir-2-DKW co-immunoprecipitate with Myc-Spir-2-DKW (Fig. 4.22).
Figure 4.22: Spir-2 proteins interact via their C-termini
Co-IP of Myc-Spir-2-DKW and eGFP-Spir-2-DKW. Myc-Spir-2-DKWwas pulled from a HEK
293 cell lysate using the anti-Myc 9E10 antibody (4 µg/ml). eGFP-Spir-2-DKW but not
eGFP was immunoprecipitated. eGFP-Spir-2-DKW was not immunoprecipitated from HEK
293 lysates when Myc-Spir-2-DKW was absent.
SDS-PAGE: 7,5% Polyacrylamide gel; Immunodetection: a-living colors GFP (1:100); a-
rabbit-HRP (1:5000); a-Myc 9E10 (1:200); a-mouse-HRP (1:4000); Abbreviations: kDa kilo
Dalton; IP immunoprecipitation; t total; s supernatant (soluble protein fraction; supernatant
fraction after centrifugation at 14000 rpm); p pellet (insoluble protein fraction; pellet fraction
after centrifugation at 14000 rpm)
This figure is representative of three separate experiments.
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To further confirm, that the Spir-2 C-termini interact directly, GST- and 6xHis-tagged Spir-
2-DKW proteins were purified and used for pull-down experiments. GST-Spir-2-DKW bound
to GST-beads was therefore incubated with eluted 6xHis-Spir-2-DKW protein. As a control,
GST bound to GST-beads were also incubated with 6xHis-Spir-2-DKW to exclude that the
binding depends on the GST-tag. 6xHis-Spir-2-DKW was pulled with GST-Spir-2-DKW but
not with GST alone (Fig. 4.23). Additionally, 6xHis-tagged Spir-1-DKW was also purified
and incubated with GST-Spir-DKW/beads, respectively GST/beads, to examine a possible
heteromerization ability of Spir proteins. The pull-down assay showed that also 6xHis-Spir-
1-DKW could be pulled with GST-Spir-2-DKW but not with GST (Fig. 4.24), suggesting a
Spir-2/Spir-1 heteromer.
Figure 4.23: Spir-2 proteins interact directly via their C-termini
Pull down of GST-Spir-2-DKW and 6xHis-Spir-2-DKW. The 6xHis-Spir-2-DKW was pulled
with GST-Spir-2-DKW but not with GST, indicating the direct interaction of Spir-2 proteins.
This figure is representative of two separate experiments.
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Figure 4.24: Spir-2 and Spir-1 interact directly via their C-termini
Pull down of GST-Spir-2-DKW and 6xHis-Spir-1-DKW. The 6xHis-Spir-1-DKW protein was
pulled with GST-Spir-2-DKW but not with GST, indicating the direct interaction between
Spir-2 and Spir-1.
This figure is representative of two separate experiments.
4.4.3 Phospholipid interaction of Spir-1 and Spir-2
FYVE domains are known phospholipid interaction modules, which mediate membrane target-
ing of several proteins. To test the interaction of the Spir FYVE domain, GST-Spir-2-DKW,
6xHis-Spir-2-DKW and 6xHis-Spir-1-DKW were purified and used for protein-lipid overlay
assays. The PH domain of the Ras GEF SOS1, which is known to bind phosphatidic acid
(Zhao et al., 2007), was used as a positive control. Purified GST protein was used as a nega-
tive control. The GST protein exhibits no binding to any phospholipid, which indicates, that
the GST-tag has no influence on the phospholipid binding property. In contrast, GST-Spir-
2-DKW, 6xHis-Spir-2-DKW and 6xHis-Spir-1-DKW exhibit a binding to phosphatidic acid,
like 6xHis-SOS1-PH (Fig. 4.25). All proteins show a binding to PtdIns(3)P, PtdIns(4)P and
PtdIns(5)P. Additionally, GST-Spir-2-DKW, 6xHis-Spir-2-DKW and 6xHis-SOS1-PH weakly
bound to PtdIns(3,4)P2, PtdIns(3,5)P2, PtdIns(4,5)P2 and PtdIns(3,4,5)P3. The binding
affinity of GST-Spir-2-DKW to PtdIns(3,5)P2 was higher in contrast to 6xHis-Spir-2-DKW.
Regarding the fact that the PH domain of SOS1 also shows a weak binding to the different
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phosphatidylinositolphosphate species that binding can be considered as unspecific. The Spir
FYVE domain could also bind to PtdIns(3)P, like other FYVE domains, regardless of the
lacking basic cluster between cysteines 2 and 3. Spir FYVE domains have therefore the ability
to bind different phospholipids. For this reason it is possible that Spir-recruitment to specific
target membranes requires further factors, such as Arf proteins.
Figure 4.25: Phospholipid binding ability of the Spir FYVE domain
Purified Spir-2-DKW, Spir-1-DKW and SOS1-PH proteins were used for protein-lipid overlay
assays. The purified PH domain of SOS1 was used as a positive control. Spir-2-DKW and
Spir-1-DKW bind to phosphatidic acid. Purified GST protein was used as a negative control.
GST alone shows no binding to any phospholipid.
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5 DISCUSSION
5.1 Spir-2 regulates actin/microtubule dependent transport of
tubular vesicles
Spir-2 is targeted to membrane structures via its C-terminal FYVE domain. The analysis
of living HeLa cells expressing eGFP-tagged Spir-2, Spir-2-DKIND and Spir-2-DKW showed
Spir-2-associated tubular structures, which differ in their length and motility. Spir-2-DKW-
associated vesicles exhibit the highest degree of elongation and furthermore, showed a slightly
increased motility (Fig. 4.3 C,D) as compared to wildtype Spir-2. In contrast, Spir-DKIND,
which encodes the four WH2 domains sufficient for in vitro actin nucleation, shows no difference
regarding the vesicle length, to full length Spir-2, but Spir-2-DKIND-associated vesicles display
a relative static behavior (Fig. 4.3 D). A possible explanation for the differences of vesicle
motility between Spir-2 and Spir-2-DKIND, could be that Spir proteins are autoinhibited. For
Spir-1, it has been shown, that a Spir-1-KIND CAAX construct recruits Spir-1-FYVE, which
is cytoplasmic, to membrane structures (Fig. 5.1). This suggests, that Spir KIND domains
have the ability to bind Spir FYVE domains, which could cause a folded Spir protein, with no
actin nucleation activity. Regarding the fact, that Spir domains are highly conserved between
different Spir proteins, the FYVE/KIND interaction is also possible for Spir-2. Spir-2-DKIND
could therefore be a dominant active Spir protein. It is therefore possible that increased actin
levels on Spir-2-DKIND vesicles disrupt their motility. Considering that Spir-2-DKW and
Spir-2-DKIND both lack the ability to bind a formin actin nucleator exhibit contrary effects
on vesicle motility, raises the question in which way the actin nucleation function of formin
contributes to the Spir-2-mediated transport of tubular vesicles.
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Figure 5.1: Spir-1 KIND-FYVE interaction
Spir-1-KIND-CAAX recruits Spir-1-FYVE to tubular membrane structures A HeLa cells were
transfected with eGFP-Spir-1-FYVE. The FYVE domain exhibits a nuclear localization. B
HeLa cells were cotransfected with eGFP-Spir-1-FYVE and Myc-Spir-1-KIND-CAAX. eGFP-
Spir-1-FYVE is recruited to membranes, suggesting a KIND-FYVE interaction of Spir-1 pro-
teins. Spir-1 proteins could therefore be autoinhibited.
By depolymerizing microtubule filaments with the drug nocodazole the data presented here
show that the elongation of this tubular vesicles is disrupted. This suggests, that an intact
microtubule cytoskeleton is necessary for the formation of those tubular vesicles. It was found
that actin is still present on the WH2-domain deficient Spir-2-DKW protein. Furthermore,
the actin dependent motor protein myosin Vb could be immunoprecipitated with Spir-2-DKW
and a good colocalization of Spir-2-DKW and MyoVb-cc-tail in living HeLa cells could also
be observed. The tail domain of myosin Vb is often used as a dominant negative mutant
for myosin Vb-dependent vesicle transport processes. This mutant has the ability to bind
myosin Vb-specific cargo but does not actively transport it. Expression of mStrawberry-tagged
MyoVb-cc-tail protein in HeLa cells shows a punctate pattern, which shows colocalization to
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Rab11a (Fig. 4.13). Coexpression of Spir-2-DKW together with MyoVb-cc-tail in living HeLa
cells change the morphology of MyoVb-cc-tail-associated vesicles. Spir-2-DKW/MyoVb-cc-
tail-positive vesicles are highly elongated also in comparison to Spir-2-DKW vesicles. Co-
expression of the full length Spir-2 protein together with MyoVb-cc-tail results also in an
elongation of MyoVb-cc-tail- associated vesicles but they have the same average length like
the Spir-2-positive vesicles. An inhibition of the nucleation activity results in highly elongated
tubular vesicles whose motility is inhibited (Fig. 4.14 and Fig. 4.16). The cooperativity of
both dominant negative effects suggests that the actin nucleation function of Spir-2 and the
actin-dependent motor activity of myosin Vb both have an effect on Spir-2-mediated vesicle
trafficking.
These results argues for a model, in which Spir-2 vesicles move along microtubule filaments,
branch and fuse with each other, and have the ability to switch to another microtubule filament.
The actin cytoskeleton is supposed to be crucial for the crossing of those Spir-2 vesicles from
one microtubule filament to another.
5.1.1 Spir-2 and Rab11a mediate vesicle transport along the same pathway
Exogenous eGFP-tagged Spir-2 and Spir-2-DKW proteins are localized to membraneous struc-
tures in HeLa cells. Coexpression of mStrawberry-tagged Rab11a revealed a colocalization of
Spir-2 and the small G protein Rab11a on tubular structures. Rab11a is involved in trans-
port processes along the secretory and the endocytic pathway (Ullrich et al., 1996, Chen et al.,
1998) and shows a localization to recycling endosomes and also to the TGN. It has been shown,
that a dominant negative Rab11 mutant (Rab11S25N) causes a block of exocytosis of VSV-G
protein and results in an accumulation of that protein into the Golgi (Chen et al., 1998).
Furthermore, the expression of Rab11S25N results in a TfR-positiv extended tubular net-
work, suggesting a role for Rab11 in vesicle budding from recycling endosomal structures
(Wilcke et al., 2000). In contrast, the expression of dominant active Rab11Q70L leads to a
dispersed, punctate pattern of TfR-positive vesicles throughout the cytoplasm (Wilcke et al.,
2000). By using markers for different transport pathways, like Shiga toxin B (STxB), which
uses the retrograde endosome to TGN route, TGN38, which cycles between the plasma mem-
brane and the TGN via endosomes, and transferrin receptor (TfR), which is a marker for the
recycling pathway, it has been shown that Rab11 plays a role in the exit of membranes from
78
the recycling endosome (Wilcke et al., 2000). The fact that after nocodazole treatment the
tubular network was no longer visible, suggests that Rab11S25N induced tubules depend on
an intact microtubule cytoskeleton.
For Spir-1-CT, a truncated version of the Spir-1 protein, which lacks the N-terminal KIND
and the four WH2 domains, it has been shown that VSV-G transport is partially blocked in
NIH3T3 cells coexpressing VSV-G and Spir-1-CT (Kerkhoff et al., 2001). This suggests, that
Spir plays a role in the regulation of post-Golgi vesicle transport. A possible function for
Spir-1 has also been shown in the endocytic pathway. Spir-1 and annexin A2 are required for
the nucleation of actin patches on early endosomal structures (Morel et al., 2009).
Although, an interaction of Spir proteins with Rab11a, Rab25 or the Rab11-interacting
protein FIP2 could not be detected here (Fig. 4.6 and Fig. 4.7), Spir-2 has an effect on the
morphology of Rab11a vesicles. The observed elongation of Rab11a/Spir-2 vesicles indicates
an active role for Spir-2 in Rab11a-regulated vesicle transport. Several studies show a coop-
eration of Rab11a and myosin Vb in recycling processes (Hales et al., 2002, Fan et al., 2004,
Swiatecka-Urban et al., 2007, Volpicelli et al., 2002, Chu et al., 2009). A Rab11a/Rab11-
FIP2/myosin Vb-complex regulates actin dependent transport of vesicles along the recycling
pathway (Hales et al., 2002, Lapierre et al., 2001). Therefore, the recruitment of Spir-2 to
Rab11a-positive membranes via binding to myosin Vb, could explain the Spir-2/Rab11a colo-
calization. This leads to the assumption, that the motor protein myosin Vb is required for
Spir-2-driven transport along the Rab11 pathway.
5.1.2 Spir-2 influences the basolateral targeting of E-cadherin in MDCK cells
It has been shown, that the basolateral transport of newly synthesized E-cadherin depends on
Rab11a. Overexpression of Rab11 disrupts the localization of E-cadherin, leading to an in-
creased intracellular localization of exogenous E-cadherin in HeLa cells (Lock et al., 2005, Lock
and Stow, 2005). E-cadherin-eGFP exits the TGN in elongated, highly motile transport carri-
ers and travels to the plasma membrane by passing Rab11-positive recycling endosomal struc-
tures (Lock and Stow, 2005). Considering the observation that Spir-2 alters the morphology
of Rab11a-positive structures, leading to highly elongated Spir-2/Rab11a-associated tubular
vesicles, suggests that Spir-2 regulates vesicle traffic along that Rab11-pathway. MDCK-cells,
which are stably transfected with Myc-Spir-2 show a loss of cell-cell contacts, a mechanism
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which is called epithelial-mesenchymal transition (EMT) (Yang and Weinberg, 2008). Anal-
ysis of E-cadherin expression revealed that E-cadherin protein levels are highly decreased in
this cell line (Fig. 5.2).
Figure 5.2: Loss of endogenous E-cadherin in MDCK-Myc-Spir-2 cells
E-cadherin expression in MDCK-Myc-Spir-2 cell. Endogenous E-cadherin was detected by
using an anti-E-cadherin antibody. ERK1 is used as a standard to show that equal amounts
of cell lysats are used. A HeLa cell lysat is used as a negative control, due to the fact that
HeLa cells don't have endogenous E-cadherin.
The functional loss of E-cadherin is a common feature of EMT (Frixen et al., 1991, Perl
et al., 1998, Schmalhofer et al., 2009). The E-cadherin loss is mediated by repression of E-
cadherin transcription. Several zinc-finger transcription factors have been found to be capable
of repressing E-cadherin transcription, these include Slug, a close relative of Snail (Hajra
et al., 2002), and two members of the ZEB family of transcription factors, ZEB1 (dEF1) (Eger
et al., 2005) and ZEB2 (SIP1) (Comijn et al., 2001). One additional attractive candidate
for downregulation of E-cadherin expression is ß-catenin. The disappearance of E-cadherin
from adherens junctions results in the release of its partner, ß-catenin, into the cytosol, which
then has the potential to enter the nucleus where it can activate transcription factors, which
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are involved in the repression of E-cadherin translation (Schmalhofer et al., 2009). Although,
the contribution of the adherens junction-associated ß-catenin pool to transcription is still
a matter of debate, several studies suggest that ß-catenin-mediated transcription can induce
the expression of Slug (Conacci-Sorrell et al., 2003) and Twist1 (Onder et al., 2008), thereby
contributing to the EMT program. A possible explanation for the loss of endogenous E-
cadherin in MDCK-Myc-Spir-2 cells is therefore, that increased Spir-2 levels disrupt Rab11-
dependent E-cadherin transport. Free ß-catenin could than induce repression of E-cadherin
transcription. Moreover, in this study it has been shown, that transfection of eGFP-Rab11a
or eGFP-Spir-2 in MDCK cells, leads to an increased intracellular distribution of endogenous
E-cadherin (Fig. 5.3), supporting the idea that overexpression of Spir-2 and Rab11a disrupts
E-cadherin transport to the plasma membrane.
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Figure 5.3: Altered E-cadherin expression
Endogenous E-cadherin in MDCK cells is localized at the plasma membrane A. The localiza-
tion of E-cadherin was determined by immunostaining (red fluorescence).
Expression of eGFP-Spir-2 B and eGFP-Rab11a C alter the E-cadherin localization resulting
in a more cytoplasmic distribution of the E-cadherin protein (white arrows).
5.1.3 An Arf1/Spir-2 complex is localized to tubular vesicles
The ADP-ribosylation factor (Arf) family of proteins belongs to the Ras superfamily of small
G proteins. The first Arf protein was identified as an allosteric activator of cholera toxin ADP-
ribosyltransferase activity (Kahn and Gilman, 1984). They have now been shown to regulate
vesicular traffic and organelle structure by recruiting coat proteins (Bonifacino and Lippincott-
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Schwartz, 2003, Nie et al., 2003), regulating phospholipid metabolism (Matteis et al., 2005,
Godi et al., 1999, 2004, Liscovitch et al., 1994, Pertile et al., 1995, Jones et al., 2000a) and
modulating the structure of actin (Myers and Casanova, 2008, Cao et al., 2005, Stamnes,
2002, Randazzo and Hirsch, 2004). All Arf proteins are myristoylated at the N-terminus, a
lipid modification that is required for biological function of Arf proteins (Antonny et al., 1997,
Goldberg, 1998, Franco et al., 1993, Liu et al., 2009). The mechanism by which the myristate
functions in Arf membrane binding is not fully understood (Serafini et al., 1991, Franco et al.,
1993). A current model suggests that myristoylation contributes to both the regulation of
guanine nucleotide exchange and stable membrane association (Liu et al., 2009). There are
six Arfs in mammals, which are structurally divided into three classes: class I, Arf1-Arf3, class
II, Arf4 and Arf5, class III contains only Arf6 (Wallace et al., 2002, Donaldson and Honda,
2005). Like the Rab small G proteins the Arf proteins cycle between a GTP-bound and GDP-
bound conformation. They require accessory proteins to facilitate nucleotide exchange. The
hydrolysis of GTP is mediated by GTPase-activating proteins (GAPs), whereas the exchange
of GDP for GTP is mediated by guanine-exchange factors (GEFs) (Donaldson and Klausner,
1994, Peyroche et al., 1996, Chardin et al., 1996).
Eukaryotic Arf GEFs can be divided into five families based on their domain organization:
Golgi BFA-resistance factor 1/BFA-inhibited GEF (GBF/BIG), Arf nucleotide binding site
opener (ARNO)/cytohesin, exchange factor for Arf6 (EFA6), Brefeldin resistant Arf GEF
(BRAG) and F-box only protein 8 (FBX8) (Casanova, 2007). All Arf GEFs contain a so called
Sec7 domain, which is highly conserved (Jackson and Casanova, 2000). The Sec7 domain is
crucial for the activation of Arfs. Most important for the activation of Arf G proteins is one
highly conserved glutamate residue at the tip of a hydrophilic loop between helix 6 and 7,
referred to as a 'glutamic finger', which is localized in the nucleotide binding fold (Renault
et al., 2003, Robert et al., 2004). Binding of a Sec7 domain to an Arf protein results in
a rotation of the Arf protein core that drives the nucleotide binding fold into the glutamic
finger, thereby displacing the bound GDP (Robert et al., 2004). The fungal toxin Brefeldin A
(BFA) inhibits the nucleotide exchange by binding to the Arf-GDP-Sec7 domain complex and
prevents the conformational changes necessary to bring the catalytic glutamate into contact
with the GDP (Klausner et al., 1992). Mammals express three BFA sensitive Arf GEFs: GBF1,
BIG1 and BIG2.
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The Arf GAPs could be subdivided into 6 groups according to their domain structure: Arf
GAP1/2/3; Git1/2; ASAP1/2/3; ACAP1/2/3; ARAP1/2/3 and AGAP1/2/3 (Randazzo and
Hirsch, 2004). Arf GAPs bind to Arf proteins, which results in the hydrolysis of GTP. It has
also been shown, that Arf GAPs bind to cargo and coat proteins, suggesting a function for
them as subunits of coat proteins rather than simply Arf regulators (Nie et al., 2003, 2005).
There is evidence that Arf GAPs are needed for sorting of cargo into vesicles and that Arf
GAP activity is sensitive for membrane curvature (Bigay et al., 2003). Until now it is not
completely understood how exactly GTP hydrolysis contributes to vesicle formation, cargo
sorting and vesicle uncoating (Nie and Randazzo, 2006).
Arf1 is a multifunctional regulator of vesicular traffic, which controls intra-Golgi traffic in ad-
dition to TGN to plasma membrane and TGN to endosome/lysosome pathways (Peters et al.,
1995, Gu and Gruenberg, 2000). It reversibly associates with Golgi membranes. Furthermore,
it has been shown, that Arf1 is also recruited to endosomal membranes (Gu and Gruenberg,
2000), where it regulates transferrin recycling (Volpicelli-Daley et al., 2005). According to the
'myristoyl-GTP switch' model Arf1 is associated with membranes in its activated, GTP-bound
conformation, whereas upon inactivation, Arf1 is released from membranes into the cytosol
(Serafini et al., 1991). Guanine nucleotide exchange triggers a conformational change in the
Arf1 protein which then exposes its N-terminal myristoyl anchor and amphipathic helix, in-
serting the myristate and the hydrophobic residues of the helix into the membrane (Antonny
et al., 1997, Goldberg, 1998). It has been shown that myristoylated Arf1-GDP partially binds
to phospholipid membranes (Franco et al., 1995) challenging the proposed 'myristoyl-GTP
switch' model. The cycle of association and dissociaton is regulated by several GEFs and
GAPs, which are specifically localized to different regions of the Golgi complex and endo-
somes (Donaldson and Klausner, 1994, Presley et al., 2002, Majoul et al., 2001). Arf1 is
crucial for the morphology of the Golgi apparatus. First, it recruits coat proteins to Golgi
membranes, such as the coat protein complex I (COPI) (Kartberg et al., 2010) and clathrin
through the recruitment of heterotetrameric adaptorprotein (AP-1, AP-3, AP-4) complexes
(Donaldson and Klausner, 1994, Faundez et al., 1998, Ooi et al., 1998), as well as monomeric
Golgi-localized g-ear-containing Arf-binding proteins (GGA) (Shiba et al., 2003). Second,
Arf1 also regulates the actin cytoskeleton on the Golgi complex. Several actin-binding and
actin-regulatory proteins localize to the Golgi (Stamnes, 2002) and some of them rapidly dis-
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sociate from the Golgi upon treatment with BFA. Drebrin, mAbp1 and cortactin are recruited
to the Golgi upon Arf1 activation (Fucini et al., 2002, Cao et al., 2005). Also the association
of Cdc42 is sensitive to BFA (Erickson et al., 1996, Myers and Casanova, 2008).
Arf1 also plays an important role in the regulation of phosphoinositides at the Golgi com-
partment. It modulates the lipid composition of the Golgi, by stimulating the activity of
phospholipidkinases and phospholipase D (Donaldson et al., 2005, Godi et al., 1999, 2004,
Haynes et al., 2005). The phosphoinositide kinase PI4K, which phosphorylates PtdIns at the
D-4 position generating PtdIns(4)P, is recruitet to Golgi membranes by Arf1 (Godi et al., 1999,
Haynes et al., 2005). Furthermore, it has been shown, that Arf1 activates both PLD isoforms
but especially PLD1, which is located at endosomes and the Golgi apparatus (Hammond et al.,
1995, 1997).
It has been shown that Arf1 induces membrane tubulation of liposomes in vitro and Arf1 in
its GTP-bound state is associated with curved membrane buds and tubules originating from
the Golgi-apparatus (Krauss et al., 2008). The N-terminal amphipathic helix is crucial for this
tubulation. This suggests, that Arf1-GTP has the ability to locally induce high curvature in
membranes and in this way drives membrane deformation. The membrane tubulation function
of Arf1 could be essential for Spir-2-associated tubular vesicles. The observation that Spir-2-
DKW interacts with Arf1, as shown in co-immunoprecipitation assays, implies, that Arf1 could
be required for the recruitment of Spir-2 to tubular vesicle membranes and that recruitment
could be regulated by the GTP-GDP cycle of Arf1 by specific Arf GEFs and GAPs. Arf GEFs
and GAPs show a specific localization pattern on membrane compartments, which determines
the regulation of Arf1 (Donaldson et al., 2005). Thus could also regulate Spir-2 function
indirectly.
5.1.4 Spir-2, Arf1 and Rab11a colocalize on the same tubular vesicles
Experimental data of this study have been shown that Spir-2-DKW alters the morphology
of Rab11a/Spir-2-DKW-positive vesicles and it is furthermore colocalized to Arf1 on tubu-
lar structures. To check if Spir-2-DKW, Arf1 and Rab11a are present on the same tubular
membranes a triple coexpression of Myc-Spir-2-DKW, eGFP-Arf1 and mStrawberry-Rab11a
was performed. Transfected HeLa cells were fixed 24 hours after transfection and Myc-Spir-2-
DKW was detected with an anti-Myc 9E10 antibody and a polyclonal Cy5-conjugated donkey
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anti-mouse secondary antibody. All 3 proteins were found on the same tubular structures (Fig.
5.4), suggesting that the different regulators of vesicle transport processes, small G proteins
of the Arf and Rab family together with an actin nucleation factor, Spir-2, mediate vesicle
transport along the same pathway.
The Arf GEF BIG2 has been shown to be implicated in the structural integrity of the
recycling endosome by activating class I Arfs (Arf1 and Arf3) (Shin et al., 2004, Shen et al.,
2006). A catalytically inactive BIG2 mutant selectively induces membrane tubules on recycling
endosomes (Shin et al., 2004), implicating a role for BIG2 in maintaining endosome structure.
It has been shown, that deletion of BIG2, by siRNA treatment, leads to an increased content
of TfR/Tf in Rab11-positive recycling endosomes, suggesting a role for BIG2 in the endocytic
pathway (Shen et al., 2006). The Arf1 GAP AGAP2 is involved in retrograde transport of
STxB from endosomes to the TGN. It has been shown that depletion of AGAP2 results in an
accumulation of STxB in transferrin-positive recycling endosomes (Shiba et al., 2010). If BIG2,
AGAP2 or other GEFs and GAPs are implicated in the regulation of Spir-2/Arf1-mediated
vesicle transport requires further investigation.
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Figure 5.4: Localization of Arf1, Spir-2-DKW and Rab11a on the same tubular
vesicles
HeLa cells were cotransfected with Arf1-eGFP, Myc-Spir-2-DKW and mStrawberry-Rab11a,
fixed, and Myc-Spir-2-DKW was detected with an anti-Myc 9E10 antibody and a secondary
Cy5-conjugated anti-mouse IgG antibody (blue fluorescence). The localization of Arf1-eGFP
and mStrawberry-Rab11a was determined by GFP and mStrawberry fluorescence. Images
were deconvoluted (blind) with the deconvolution software from Leica. 3 tubular vesicles,
which are associated with Rab11a, Spir-2-DKW and Arf1 are indicated (white arrows).
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5.1.5 The Spir-box and FYVE domain containing C-terminus of Spir-2 and
Spir-1 is a phospholipid-binding module
FYVE domains are known phospholipid interaction modules, which mediate the binding to
phosphatidylinositol 3-phosphat (PtdIns(3)P). In contrast to that, Spir consists of a modified
FYVE domain, lacking the basic cluster between cysteines 2 and 3 and having a loop insertion
between cysteines 6 and 7. Therefore, it was tempting to speculate that Spir facilitates binding
to other phospholipid species than PtdIns(3)P. Experiments of this study show, that Spir-1-
DKW and Spir-2-DKW bind to phosphatidic acid (PA).
The small phospholipid phosphatidic acid is generated by phospholipase D (PLD). PLD1 is
found throughout the cell, primarily localizes to perinuclear endosomes and the Golgi appa-
ratus (Brown et al., 1998, Freyberg et al., 2001, Hughes and Parker, 2001). PLD2 is mostly
localized at the plasma membrane (Czarny et al., 1999). PA is a versatile second messenger,
which plays a role in many cellular processes like membrane trafficking and actin cytoskeleton
remodeling (Jenkins and Frohman, 2005). PLD is regulated by protein kinase C isoforms,
small G proteins of the Rho and Arf family (Hammond et al., 1995, 1997, Henage et al., 2006,
Hiroyama and Exton, 2005, Sung et al., 1999, Frohman et al., 2000) and, particularly, by
the phosphoinositide phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) (Liscovitch et al.,
1994, Pertile et al., 1995). PA stimulates PIP5K, recruits proteins to specific membranes by
binding to phospholipid binding-domains, like the PH domain of SOS1 (Zhao et al., 2007), and
facilitates membrane curvature. PA favors negatively curved membranes and could therefore
play a role in vesicle formation (Roth, 2008).
PA is also localized to the Golgi apparatus. Inhibition of PA generation alters the structure
of the Golgi apparatus and blocks TGN exit (Siddhanta et al., 2000). This supports a role
for PA in promoting vesicle formation at the TGN. Considering that PA is generated by
phospholipase D (PLD), which is activated by Arf proteins (Hammond et al., 1995, 1997,
Henage et al., 2006, Hiroyama and Exton, 2005) Arf1 could recruit Spir-2 to membranes in
two ways, first, by activation of PA synthesis and second, by binding to Spir-2. PA has a
small polar head group and is more stable in a membrane with negative curvature. Therefore
it is likely, that PA induces or facilitates negative curvature of membranes. Considering the
tubular morphology of Spir-2-associated vesicles, it is possible that Spir-2 is recruited to specific
membranes in an Arf1/PA-dependent manner. According to the coincidence detection code
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model (Paolo and Camilli, 2006) higher affinities and thus more stable protein-membrane
interaction could be achieved by parallel binding of two or more factors. Other studies have
shown that Arf G proteins promote release of nascent secretory vesicles from the TGN and
this depends on an enhancement of PLD activity (Chen and Shields, 1996, Chen et al., 1997).
5.1.6 Spir-2 proteins could perform homotypic and heterotypic interaction via
their C-terminal parts
To further elucidate mechanisms in which Spir protein function could be regulated, homo- and
hetero-interaction studies were performed. In this study it has been demonstrated that Spir-2
has the ability to directly interact with another Spir-2 protein via its C-terminal part but also
with a C-terminally Spir-1 protein. Cotransfection of Spir-2 and Spir-1 proteins in HeLa cells
revealed a similar but not identical localization pattern of both proteins. Several structures
could be detected, which are Spir-2/Spir-1-positive but there are also several structures, which
contain just one of the proteins (Fig. 5.5). The fact that Spir-1 and Spir-2 both show colocal-
ization to Rab11a and display a similar phospholipid binding pattern, suggests that they are
recruitet to the same membranes.
Hypothetically, Spir recruitment to membranes could require dimerization, like it has been
shown for EEA1, in which the formation of an EEA1 dimer is crucial for the binding to
early endosomes (Dumas et al., 2001). Dimerization could also be required for the binding to
PA, Arf1 or myosin Vb. Another possibility for the role of Spir dimerization could be, that
Spir autoinhibition by binding of the KIND domain to the FYVE domain could be removed.
Theoretically, KIND domains and FYVE domains could compete with each other in terms
of binding to another FYVE domain. If and in which way dimerization regulates Spir actin
nucleation needs further investigation.
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Figure 5.5: Localization of Spir-2 and Spir-1 in HeLa cells
HeLa cells were cotransfected with expression vectors directing the expression of eGFP-Spir-2
and Myc-Spir-1. Cells were fixed and protein localization was determined by immunostain
experiments. Spir-2 and Spir-1 proteins exhibit a similar cellular localization. Several Spir-
2/Spir-1-associated vesicles are present, suggesting a Spir-2/Spir-1 heteromer.
5.1.7 Spir-2 mediated vesicle transport: secretory or endocytic pathway?
Spir-2 regulates vesicle transport in a myosin Vb-dependent manner. The actin-dependent
motor protein myosin Vb is implicated in the regulation of recycling traffic together with
Rab11a/Rab11-FIP2. Spir-2 also interacts with the small G protein Arf1, which plays a role
in the formation of nascent secretory vesicles at intra-Golgi structures and at the TGN (Chen
and Shields, 1996, Chen et al., 1997). This raises the question on which pathway Spir-2
acts. Arf1 also regulates the phospholipid environment by activating PLD, thereby generating
PA and increasing PIP2 levels (Hammond et al., 1995, 1997, Jones et al., 2000b). PA is
located on membranes with negative curvature and facilitates vesicle formation at the TGN
like Arf1 (Siddhanta and Shields, 1998, Siddhanta et al., 2000, Roth, 2008). There are several
interconnections between the endocytic and the secretory pathway. The TGN, as an important
sorting station for secreted proteins also receives retrograde membrane traffic (Gleeson et al.,
2004, Bonifacino and Rojas, 2006). The proposed 'tubular endosomal network' (Bonifacino
and Rojas, 2006), challenges the idea in which the endosomal system has a stable appearance.
That new model proposes an endosomal network consisting of several specific domains with
various connections to specific target membrane compartments, for example the TGN.
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There are two independent retrograde pathways from early endosomes to the TGN. On
the one hand traffic from early endosomes to the Golgi via late endosomes, using cation-
independent mannose 6-phosphate receptor (CI-MPR) as a marker (Lombardi et al., 1993,
Ganley et al., 2004, Pfeffer, 2009), otherwise there is also a direct route from early endosomes
to the Golgi. Shiga toxin B-fragment (STxB) and TGN38 use this pathway (Mallard et al.,
1998, Ghosh et al., 1998, Pfeffer, 2009). Clathrin/AP-1 coats may be involved in retrograde as
well as anterograde transport between TGN and endosomes. Previous studies have indicated
a role for clathrin, the clathrin adaptor AP-1 and the retromer complex in retrograde sorting
from early/recycling endosomes to the TGN. (Popoff et al., 2007, Natsume et al., 2006).
Depletion of clathrin results in the accumulation of STxB in recycling endosomes. Traffic
through the early/recyling endosome to TGN pathway could pass Rab11-positive recycling
endosomal structures. Overexpression of Rab11 mutants affects the transport of STxB to
the TGN (Wilcke et al., 2000). Rab11a/b and its binding protein FIP1/RCP are required
for the retrograde delivery of TGN38 and Shiga toxin from early/recycling endosomes to the
TGN, but not for the retrieval of cation-independent mannose 6-phosphate receptor from late
endosomes (Jing et al., 2010). Arf1 and its GAP AGAP2 have also been shown to be involved
in retrograde transport processes from endosomes to the TGN (Shiba et al., 2010). AGAP2
depletion results in an accumulation of STxB in transferrin-positive recycling endosomes (Shiba
et al., 2010).
It has been shown that Rab11 is also involved in the exit of membranes from the recycling
endosome (Wilcke et al., 2000), and that an intact microtubule cytoskeleton is necessary
for that vesicle transport. Spir-2 and Rab11a are located at the same vesicles and Spir-2
alters the morphology of Rab11a-associated vesicles. Moreover, elongation of Spir-2 vesicles is
also microtubule-dependent, suggesting that Spir-2 together with Rab11a and/or Arf1 maybe
regulate retrograde transport from endosomal structures back to the TGN, or could be crucial
for the maintainance of the 'tubular endosomal network' by regulating vesicle fusion and/or
fission of that membraneous structure. Arf1 could be the crucial factor for Spir-2 recruitment
to PA-enriched membranes. Spir-2 could furthermore be involved in basolateral transport of
E-cadherin. E-cadherin is transported from the TGN to the plasma membrane by passing
recycling endosomal structures (Lock and Stow, 2005, Lock et al., 2005), respectively Rab11-
positive compartments of the 'tubular endosomal network'. Moreover, it remains an open
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question, if Spir-2 regulates TGN to endosome traffic, exit of vesicles from endosomes, such as
retrograde traffic from endosomal structures to the TGN, or anterograde traffic from endosomes
to the plasma membrane.
Figure 5.6: Model of Spir-2 recruitment to intracellular membranes
The C-terminal part of Spir-2, consisting of the Spir-box and the modified FYVE zinc finger
is crucial for the membrane targeting and therefore for the function of Spir proteins in vesicle
transport processes. Arf1 regulates PA synthesis at membranes by activating PLD and has
the ability to locally induce high curvature in membranes and in this way drives membrane de-
formation. The membrane tubulation function of Arf1 could be essential for Spir-2-associated
tubular vesicles. Arf1 could be required for the recruitment of Spir-2 to tubular vesicle mem-
branes and that recruitment could be regulated by the GTP-GDP cycle of Arf1 by specific Arf
GEFs and GAPs. The actin and the microtubule cytoskeleton has an important impact on
Spir-2-mediated vesicle transport processes. An intact microtubule cytoskeleton is necessary
for the elongation of Spir-2-associated tubular vesicles. It was found that actin is still present
on the WH2-domain deficient Spir-2-DKW vesicles and Spir-2-DKW is in a complex with the
actin-dependent motor protein myosin Vb. Spir-2 vesicles move along microtubule filaments,
branch and fuse with each other, and have the ability to switch to another microtubule fila-
ment. The actin cytoskeleton is supposed to be crucial for the crossing of those Spir-2 vesicles
from one microtubule filament to another.
92
Appendix I Supplemental table I: Primersequences
All primers were acquired from MWG BIOTECH of standard HPSF quality, diluted in H2O
to 10 pm/µl and stored at -20°C.
Primer name Sequence 5'-3' annotation
NcoI mSpir-1-CT long 5'
5' CATG CCATGG GA CCA
GAA GAA ATT AGA CGG
AGC 3'
cloning of pProEX
HTb-mm-Spir-1-DKW
m-Spir-1-CT XhoI 3'
5' CCG CTCGAG TCA
GAT CTC GTT GAT AGT
CCG 3'
BamHI Myc hSpir2 375 st 5'
5' GC GGATCC GCC GCC
GCC ATG GAG CAG AAG
CTG ATC TCC GAG GAG
GAC CTG ATC CTC AAC
GCC TGC TCC 3'
cloning of pcDNA3-Myc-hs-
Spir-2-DKW
hSpir2 375 EcoRV 3'
5' GATATC TCA CTT GAA
GTC AAG AGT CCT GGT
3'
EcoRI hFIP2 5'
5' CG GAATTC T ATG
ATG CTG TCC GAG CAA
GCC 3'
cloning of
pEGFP-C1-hs-FIP2
hFIP2 BamHI 3'
5'CG GGATCC TTA ACT
GTT AGAGAA TTT GCC
AGC TTT TCC 3'
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HindIII hMyoVb 5'
5' CCC AAGCTT C GAG
GCC CGC TCA GCA GAG
3'
cloning of
mStrawberry-hs-MyoVb tail
hMyoVb XbaI 3'
5' GC TCTAGA GAC TTC
ATT GAG GAA TTC CAG
ATT 3'
KpnI hArf1 st5'
5' GG GGTACC GCC GCC
GCC ATG GGG AAC ATC
TTC GCC AAC CTC 3'
cloning of pEGFP-N3-hs-Arf1
hArf1end BamHI3'
5' CG GGATCC CTT CTG
GTT CCG GAG CTG ATT
3'
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Appendix II Supplemental table II: Construct overview
Construct Description
Fragment
boundaries
(Restriction sites)
Purification Purpose
pcDNA3-Myc-hs-
Spir-2-DKW
Myc-Spir-2-
DKW
aa 388-728
BamHI/EcoRI
cell imaging,
co-immuno-
precipitation
pEGFP-N3-hs-
Arf1
Arf1-eGFP KpnI/BamHI
cell imaging,
co-immuno-
precipitation
pEGFP-C1-hs-
Spir-2
eGFP-Spir-2 BamHI/XbaI cell imaging
pEGFP-C1-hs-
Spir-2-DKW
eGFP-Spir-2-
DKW
aa 375-728
EcoRI/XbaI
cell imaging
pEGFP-C1-hs-
Spir-2-DKIND
eGFP-Spir-2-
DKIND
aa 244-728
EcoRI/KpnI
cell imaging
pEGFP-C1-hs-
Rab11-FIP2
eGFP-Rab11-
FIP2
EcoRI/BamHI
co-immuno-
precipitation
mStrawberry-hs-
MyoVb-cc-tail
mStrawberry-
MyoVb-cc-tail
aa 909-1849
HindIII/XbaI
cell imaging,
co-immuno-
precipitation
pEGFP-cl-
Rab11a
(kindly provided
by Marino Zerial)
eGFP-Rab11a
cell imaging
co-immuno-
precipitation
mStrawberry-
mm-
Rab11a
mStrawberry-
Rab11a
EcoRI/BamHI
cell imaging
co-immuno-
precipitation
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mStrawberry-
mm-
Rab25
mStrawberry-
Rab25
EcoRI/XbaI
co-immuno-
precipitation
mStrawberry-
mm-
Rab6a
(pEGFP-C2
vector backbone)
mStrawberry-
Rab6a
EcoRI/BamHI cell imaging
pEGFP-C1-Spir-
1-FYVE
eGFP-Spir-1-
FYVE
aa 586-715
XhoI/BamHI
cell imaging
pcDNA3-Myc-
Spir-1-KIND-
CAAX
Myc-Spir-1-
KIND-CAAX
BamHI/EcoRI cell imaging
pGEX-4T-3-hs-
Spir-2-DKW
GST-Spir-2-
DKW
aa 375-728
BamHI/XhoI
Glutathione
Sepharose 4b
resin
(Amersham)
pull down,
phospholipid
overlay assay
pProEX
HTb-mm-
Spir-1-DKW
6xHis-Spir-1-
DKW
aa 160-515
NcoI/XhoI
Ni-NTA
matrix
(Qiagen)
pull down,
phospholipid
overlay assay
pProEX HTb-hs-
Spir-2-DKW
6xHis-Spir-2-
DKW
aa 375-728
BamHI/XhoI
Ni-NTA
matrix
(Qiagen)
pull down,
phospholipid
overlay assay
pProEX HTb-hs-
SOS1-PH
6xHis-SOS1-
PH
aa 422-551
BamHI/XhoI
Ni-NTA
matrix
(Qiagen)
phospholipid
overlay assay
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List of Abbreviations
ACAP Arf GAP with coiled-coil domains, ANK repeats and PH domain
ADF actin-depolymerizing factor
AGAP Arf GAP with GLD domain, ANK repeats and PH domain
AMPA alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
AP-1,-2,-3,-4 adaptorprotein 1, 2, 3 and 4
APS Ammonium persulfate
ARAP Arf GAP with Rho GAP domain, ANK repeats and PH domain
Arf ADP-ribosylation factor
ARNO Arf nucleotide binding site opener
Arp2/3 actin-related protein 2 and 3
ASAP Arf GAP with SH3 domain, ANK repeats and PH domain
BCP 1-bromo-3-chloropropane
BFA Brefeldin A
ADP adenosin diphosphate
ATP adenosin triphosphate
eGFP enhanced green fluorescent protein
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FYVE Fab1p, YOTB, Vac1p, EEA1
GST glutathione S-transferase
KIND kinase noncatalytical C-lobe domain
bp base pairs
BRAG Brefeldin resistant Arf GEF
BSA Bovine serum albumin
CAAX 'C' is Cysteine, 'A' is an aliphatic amino acid, and 'X' is variable
Capu Cappuccino
Cdc42 Cell division cycle 42
cDNA complementary DNA
CI-MPR cation-independent mannose 6-phosphate receptor
Co-IP co-immunoprecipitation
Cobl Cordon-bleu
COPI/II coat protein complex I and II
Cy5 Cyanine 5
DAAM dishevelled-associated activator of morphogenesis
DAD diaphanous autoregulatory domain
DEPC Diethyl Pyrocarbonate
Dia diaphanous
DID diaphanous inhibitory domain
DMEM Dulbecco's modified Eagle's medium
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DMSO Dimethyl Sulfoxide
DNA Deoxyribonucleic acid
E-cadherin epithelial cadherin
E. coli Escherichia coli
ECL enhanced chemiluminescent light detection
EDTA Ethylenediaminetetraacetic acid
EEA1 early endosome antigen 1
EFA6 exchange factor for Arf6
EMT epithelial-mesenchymal transition
ERK1 extracellular-signal-regulated kinase 1
ERM Ezrin Radixin Moesin
F-actin filamentous actin
FBX8 F-box only protein 8
Fc-region fragment crystallizable region
FCS fetal calf serum
FH1 formin homology 1
FH2 formin homology 2
FHOD formin homology domain-containing protein
FIP2 family of interacting proteins
FITC Fluorescin isothiocyanate
FRL formin-related gene in leukocytes
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FSI formin-Spir-interaction site
G proteins guanine nucleotide-binding proteins
G-actin globular actin
GAP GTPase-activating protein
GDF GDI-displacement factor
GDI GDP-dissociation inhibitor
GDP Guanosine diphosphate
GEF guanine nucleotide exchange factor
GGA Golgi-localized gamma-ear-containing Arf-binding protein
GGTase geranylgeranyltransferase
Glu Glutamate
GST glutathione S-transferase
GTP Guanosine-5'-triphosphate
HEK 293 human embryonic kidney 293 cells
HeLa an immortal cell line derived from cervical cancer cells taken from Henrietta Lacks
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
His Histidine
HRP horseradish peroxidase
IgG Immunoglobulin G
INF1/2 inverted formin 1 and 2
IP Immunoprecipitation
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IPTG Isopropyl beta-D-1-thiogalactopyranoside
JMY junction-mediating regulatory protein
kb kilo bases
kDa kilo Dalton
L-3 linker region 3
LB luria bertani
Lmod-2 Leiomodin-2
LTP long-term potentiation
mA milliampere
mAbp1 mammalian actin-binding protein 1
MCS multiple cloning site
MDCK Madin-Darby canine kidney epithelial cell line
ml milliliter
mM millimolar
MOPS 3-(N-Morpholino)propanesulfonic acid
MWCO molecular-weight cutoff
NEB New England Biolabs
Ni-NTA nickel-nitrilotriacetic acid
NPF nucleation promoting factor
OD Optical density
PA phosphatidic acid
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PAGE Polyacrylamide gel electrophoresis
PBS phosphate buffered saline
PCR polymerase chain reaction
Pen Penicillin
PFA Paraformaldehyde
Pfu Pyrococcus furiosus
PLD phospholipase D
PtdIns(3)P Phosphatidyl 3-phosphat
PtdIns(3,4)P2 Phosphatidyl 3,4-bisphosphat
PtdIns(3,4,5)P3 Phosphatidyl 3,4,5-trisphosphat
PtdIns(3,5)P2 Phosphatidyl 3,5-bisphosphat
PtdIns(4)P Phosphatidyl 4-phosphat
PtdIns(4,5)P2 Phosphatidyl 4,5-bisphosphat
PtdIns(5)P Phosphatidyl 5-phosphat
Rab Ras-related in brain
RBD Rab Binding Domain
RCP Rab coupling protein
REP Rab escort protein
rpm rounds per minute
RT-PCR Reverse transcriptase PCR
SCAR suppressor of cAMP receptor
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SDS Sodium dodecyl sulfate
SH3 SRC homology 3
SOS1 son of sevenless 1
Strep Streptomycin
STxB Shiga toxin B
Taq Thermus aquaticus
TARP translocated actin recruiting phosphoprotein
TBST Tris-Buffered Saline-Tween
TEMED Tetramethylethylenediamine
Tf Transferrin
TfR Transferrin receptor
TGN trans-Golgi network
TRITC Tetramethyl Rhodamine Isothiocyanate
tRNA transfer RNA
VSV-G Vesicular stomatitis virus glycoprotein
WASH WASP and SCAR homologue
WASP Wiskott-Aldrich syndrome protein
WAVE WASp family verprolin homologous protein
WB Western Blot
WH2 WASP-homology
WHAMM Wiskott Aldrich syndrome protein homologue associated with actin, golgi mem-
branes and microtubules
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WHIF1 WH2 domain-containing formin 1
ZEB1/2 Zinc finger E-box-binding homeobox 1 and 2
ºC degree Celsius
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